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Abstract 
Bacterial vaginosis (BV) and periodontal disease (PD) are conditions characterised by 
reduction of healthy bacterial communities in the vaginal and oral microbiomes 
respectively.  Both BV and PD are associated with an increased risk of preterm labour 
and negative birth outcomes, yet it is unknown whether PD and BV are independent 
risk factors or may be interrelated. Understanding the health risks associated with 
pregnancies in young women is critical for developing new preventative interventions 
and for informing guidelines. Current knowledge of what constitutes a healthy 
microbiome is largely based on North American studies and may not be applicable to 
the South African population. This study characterises the oral and vaginal 
microbiome of South African female adolescents and investigates the association 
between alterations in oral bacterial diversity and BV in young South African women. 
DNA was extracted from matched lateral vaginal wall, saliva and periodontal samples 
and V4 16S sequencing was performed using MiSeq technology. The composition of 
the core oral microbiome of South African female adolescents was found to be similar 
to descriptive studies published in other populations. We additionally report a 
description the vaginal microbiome that is in agreement with previous studies in the 
South African population. PD-associated bacterial species were enriched in the oral 
microbiome of women with clinically diagnosed BV and in those with Lactobacillus 
iners dominant vaginal community types (VCTs) compared to asymptomatic women 
and those with L. crispatus dominated VCTs respectively. While this data provides 
evidence in support of a relationship between oral and vaginal dysbiosis, it unclear in 
which compartment bacterial dysbiosis would originate, should the association holds 
true.  
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CHAPTER ONE: Literature review 
1.1 The human microbiome 
1.1.1 Introduction 
The composition of the bacterial microbiome, the collection of bacterial microorganisms in the 
human body, has an important influence on human health (reviewed by Cho and Blaser 2012). 
Bacterial communities residing in different ecological niches within the human body play a large 
part in shaping immunity, development, physiology and nutrition. These distinct anatomical sites 
in the human body provide unique microhabitats supporting the growth of distinct microbial 
communities (Figure 1.1, Cho and Blaser 2012).  It was originally understood that the human 
microbiome is acquired only after birth, but recent studies identifying low abundance microbial 
communities within the placenta have challenged the paradigm that the foetus exists in a sterile 
environment in utero (Aagaard et al. 2014). The infant microbiome is seeded from the maternal 
vagina and faeces (Mändar and Mikelsaar 1996) and mode of delivery (vaginal or via caesarean 
section) plays a role in the initial composition of the infant microbiome (Dominguez-bello et al. 
2010; Chu et al. 2017).  
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Figure 1.1: Differential composition of bacterial communities in different anatomical sites in the human body. 
Bacterial communities sampled from the same anatomical site from different individuals have been found to be 
more similar to each other than bacterial communities from different sites in the same individual (Sonnenburg and 
Fischbach, 2011). At the phylum level, bacterial communities have been found to be longitudinally stable within the 
same anatomical sites amongst different individuals. These stable bacterial communities have been described as 
“core” or “optimal” microbiomes. Core microbiomes have a mutualistic relationship with the human host and play 
a large role in maintaining host health. Adapted from: Cho, I., & Blaser, M. J. (2012). The human microbiome: at the 
interface of health and disease. Nature Reviews Genetics, 13(4), 260. 
 
The composition of these microbial communities changes throughout our lifetime in response to 
hormonal fluctuations, host genetics and environmental exposures (The Human Microbiome 
Project Consortium 2012). The majority of microbiota play a mutualistic role within the human 
body, surviving off nutrients provided by the human host, while providing a first line of defence 
from opportunistic pathogens (Costello et al. 2012). Commensal bacteria maintain host health by 
competitively excluding invasive species from colonizing ecological niches and producing defence 
factors that hinder a pathogen’s ability to multiply and/or produce virulence factors (Costello et 
al. 2012). Microbial dysbiosis, characterised by the reduction of mutualistic indigenous bacterial 
communities, results in the outgrowth of opportunistic pathogens causing chronic infections and 
potentially life threatening disease (Lloyd-Price et al. 2016). The ‘core’ microbiome refers to the 
most stable microbiota within an ecological niche that are shared by the majority of healthy 
individuals, whilst the ‘variable’ microbiome is determined by individual genetics, life-style and 
environmental exposures  (Turnbaugh et al. 2007). There is a global interest in defining a ‘healthy’ 
or ‘optimal’ microbiome in order to better understand how deviations from stable microbial 
communities impact human health and disease.  
 
1.1.2 Culture-independent bacterial classification 
Historically, our knowledge of the composition of the human microbiome was limited to the 
<0.01% of bacterial species? that are amenable to laboratory cultivation (Amann et al. 1995). The 
advent of culture-independent approaches has resulted in a rapid deepening of our 
understanding of the composition and ecological function of the human microbiome. Advances 
in next-generation genetic sequencing of the 16S hypervariable region of the bacterial ribosomal 
gene has significantly expanded our knowledge of bacterial diversity (Clarrdige 2004). This region 
of the bacterial chromosome has been exploited in describing bacterial diversity due to its unique 
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combination of evolutionary conserved regions alongside hypervariable regions - allowing for 
species level classification of bacterial phyla (Van de Peer et al. 2013). There are nine distinct 
hypervariable regions within the 16S region, numbered V1 to V9 (Chakravorty et al. 2008). 
Different variable regions have been shown to exhibit higher levels of variability for specific 
bacterial phylum and to provide varying amounts of species level resolution for selected bacterial 
families. V1 demonstrates high level resolution for Streptococcus and Staphylococcus species, V2 
for Mycobacterial species and V3 for Haemophilus species (Chakravorty et al. 2008). The V4-6 
region is conventionally used as representative barcode for the majority of bacterial phyla (Yang 
et al. 2016), although studies have found difficulty in identifying Fusobacterium species in this 
region (Kumar et al. 2011).  
 
The development of high throughput next-generation sequencing (NGS) platforms has 
revolutionized genetics and genomic research, making high resolution, species level classification 
of non-culturable bacteria both possible and affordable. While a number of NGS platforms have 
been developed over the past ten years (Reviewed by Lin Liu et al. 2012), Illumina® sequencing-
by-synthesis technology has emerged as an industry leader. In comparison to other NGS 
platforms, Illumina® technology delivers DNA sequencing data with the highest accuracy and 
lowest error rates per reads (Ross et al. 2013; Nakazato et al. 2013). The Illumina® MiSeq desktop 
sequencer, developed for research laboratories and clinical diagnostics, provides rapid and high 
quality 16S data for small scale studies (Liu et al. 2012). For the purpose of 16S sequencing, DNA 
libraries are prepared using polymerase chain reaction (PCR) to amplify the 16S bacterial 
chromosome using universal primers targeting the highly conserved regions alongside the 
hypervariable regions. Library preparation involves two rounds of PCRs; the first usually amplifies 
the desired region of 16S chromosome and the second to ligate specialized Illumina adapters 
containing index sequencing to the end of PCR amplicons (Figure 1.2). Indexed amplicons are 
pooled and loaded onto a flow cell where the amplicons hybridize to the flow cell’s surface by 
the complementary chemistry of the ligated index barcodes. Each fragment is then amplified into 
distinct, clonal clusters through bridge amplification. Clonal clusters are then sequenced using 
proprietary sequencing-by-synthesis incorporating fluorescently labeled reversible-terminator 
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nucleotides. Four fluorescently labeled nucleotides, complementary to the cluster fragments, are 
incorporated into a DNA strand. With each labeled nucleotide incorporated, a fluorescent signal 
specific to the DNA base incorporated is emitted and recorded. The signals are recorded as 
fragment reads and filtered by the MiSeq sequencer to remove low quality reads. Reads from 
specific samples are identified by their unique index sequences. Raw sequence reads are then 
aligned to a reference genome using bioinformatics software (Figure 1.2). 
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Figure 1.2: Illumina® Miseq workflow. (A) The bacterial 16S chromosome is amplified using PCR with primers 
targeting the evolutionarily conserved regions that flank hypervariable stretches. A second round of PCR ligates 
Ilumina® MiSeq adaptors containing unique barcodes to amplified products. (B) Pooled libraries are amplified on 
flow cells using bridge amplification to produce clonal clusters containing numerous replicas of amplified fragments. 
(C) Clonal clusters are sequenced using sequencing-by-synthesis technology before (D) raw read data is quality 
checked and aligned to reference genomes using bioinformatics software. Adapted from: 
https://www.illumina.com/documents/products/illumina_sequencing_introduction.pdf, [accessed on 18 July 2018] 
 
1.1.3  Bioinformatic analysis 
NGS methods generate large sequencing datasets that require robust bioinformatic tools for 
quality assessment and alignment of raw read data to curated reference genomes. Sequenced 
reads are compared to reference genomes in peer-reviewed and curated genomic databases, 
assigning bacterial identity and phylogeny to allow for rapid and sensitive taxonomic annotation. 
This is routinely done using the basic local alignment tool (BLAST; Edgar 2010) to identify and 
assign operational taxonomic units (OTUs) to sequence data against peer-reviewed genome 
databases, such as Greengenes or SILVA (Desantis et al. 2006; Pruesse et al. 2007), using the RDP 
classifier (Wang et al. 2007). Additional phylogenetically curated databases have been developed 
for the analysis of 16S rDNA data from specified anatomical niches in the human microbiome 
(Griffen et al. 2011). Common downstream ecological analysis of annotated taxonomic data 
includes assessing the bacterial diversity within a sample (alpha-diversity) and the relative 
bacterial diversity between samples (beta-diversity; Whittaker, Willis, and Field 2001). Alpha 
diversity is routinely calculated by the Shannon Diversity Index, a statistic representing the 
number of species and distribution of OTUs in a sample (Spellerberg & Fedor 2003). Beta-diversity 
measures [such as Bray Curtis (Curtis & Roger Bray 1957) or UniFrac (Lozupone et al. 2010)] are 
calculated based on the extent of overlap between defined parameters between two samples, 
for example phylogenetic distance or OTUs. Diversity measures are commonly visualised using 
multivariate statistics, such as principal component analysis (PCoA) and non-metric 
multidimensional scaling (NMDS; Faith, Minchin, and Belbin 1987; Gower 1966). 
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1.2 The oral microbiome 
1.2.1 Defining a core microbiome 
After the gut, the oral cavity has the most diverse bacterial composition compared to other sites 
in the human body, with more than 700 bacterial species identified (Dewhirst et al. 2010; Aas et 
al. 2005). In comparison to the vaginal and gut-microbiome, the oral microbiome most closely 
resembled the placental microbiome on a phylum level (Aagaard et al. 2014) and the placenta is 
believed to play a role in the development of prenatal tolerance to the maternal oral microbiome 
(Verma et al. 2018). Although the mechanisms determining the pioneer oral microbiome are not 
well understood, it is hypothesized that the placenta acts as an antigen collection site, seeded by 
maternal oral bacteria through a hematogenous route, and presented to the foetus to train 
immune tolerance (Zaura et al. 2014). Both, mode of delivery (vaginal or via caesarean section) 
and method of feeding (breast- or formula-fed) have shown to significantly impact the 
composition of the infant oral microbiome (Holgerson et al. 2013; Li et al. 2005) 
 
Despite the number of physical and chemical exposures the oral cavity experiences on a daily 
basis, research suggest that a stable oral microbiome exists (Li et al. 2013; Zaura et al. 2009). NGS 
found 47% of species level OTUs to be shared between the oral microbiomes of three individuals 
(Zaura et al. 2009). The core oral microbiome contains six major phyla (Figure 1.3), representing 
96% of oral bacteria found in the saliva of healthy individuals, namely: Firmicutes, Bacteroidetes, 
Proteobacteria, Actinobacteria, Spirochaetes and Fusobacteria (Dewhirst et al. 2010; Bik et al. 
2010; Zaura et al. 2009). Firmicutes has been found to be the most prevalent bacteria, 
representing 37% of the oral microbiome, followed by Bacteroidetes (17.1%), Proteobacteria 
(17.1%), Actinobacteria (11.6%), Spirochaetes (7.9%) and Fusobacteria (5.2%) (Dewhirst et al. 
2010). The extent to which host genetics determine the composition of the oral microbiome is 
not well understood. While one study found that the salivary microbiome did not vary across 
twelve locations worldwide (Nasidze et al. 2009), another study comparing saliva from Alaskan, 
German and African individuals found significantly higher bacterial diversity in the oral 
microbiomes of Africans compared to those from Northern countries (Li et al. 2014). Authors 
concluded that ethnicity was a stronger determinant of oral microbiome composition than age, 
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gender and dietary habits (Li et al. 2014). In a study of 2,343 healthy individuals, Neisseria and 
Haemophilus were found to dominate the salivary microbiome of Korean individuals, while 
Prevotella and Veillonella were most prevalent amongst Japanese individuals (Takeshita et al. 
2016).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Phylogenetic visualization of 16S data in the CORE database. This database was created by using a list 
of bacteria gathered from a number of published studies surveying the oral microbiome and 16S sequence data from 
GenBank (Griffen et al. 2011). The oral microbiome was found to consist of predominately Firmicutes, 
Proteobacteria, Bacteriodes, Actinobacteria, Spirochaetes, Fusobacteria and TM7. Genera are colour-coded by 
phylum, except for the Firmicutes and Proteobacteria, which are shown at the level of class. Adapted from 
(Costalonga & Herzberg 2014) 
 
 
 
1.2.2 Ecological niches within the oral cavity 
The structure of the oral cavity leads to the formation of different ecological niches, causing 
colonization by distinct bacterial community types. Mucosal surfaces including the palate, 
Figure 4. CORE microbiome of oral cavity
The tree was generated with RAxML BlackBox Web server [154] and viewed in ITOL 
[155]. Gener  are color-coded by phyla, except for the Firmicut s nd Proteobacteria, which 
are shown at the level of class (Adapted from [6]).
Costalonga and Herzberg Page 29
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tongue, cheeks and tonsils house a variety of shedding bacteria that accumulate in saliva, whilst 
the enamelled covered surface of teeth or dentures favour the long-term formation of bacterial 
biofilms (Costalonga & Herzberg 2014). While Firmicutes and Bacteroidetes are most prevalent 
in all oral niches, Segata et al. (2012) found three distinct microbial communities when comparing 
microbiota sampled from seven different locations in the oral cavity. The microbial composition 
of the buccal mucosa, keratinized gingiva, and hard palate were dominated by Firmicutes 
followed in decreasing order of relative abundance by Proteobacteria, Bacteroidetes and either 
Actinobacteria or Fusobacteria (Segata et al. 2012). Saliva, tongue, tonsils, and throat 
communities contained fewer Firmicutes and relatively larger proportions of Bacteroidetes, 
Fusobacteria, Actinobacteria and TM7 (Segata et al. 2012). Samples from the teeth, including 
both the sub- and supra-gingival plaque had the lowest proportion of Firmicutes and relatively 
larger proportion of Actinobacteria (Segata et al. 2012). These findings are in line with other 
studies, showing the oral mucosal surfaces to be largely dominated by Firmicutes and the dental 
plaque to host a more diverse range of Firmicutes, Bacteriodetes, Actinobacteria, Proteobacteria 
and Fusobacteria (He et al. 2015; Aas et al. 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Proportions of different genera recovered from whole saliva of healthy adults
Saliva was collected from a group of 71 healthy individuals by mouthrinse with 10 mL UV-
irradiated sterile saline for 30 sec and stored at −80°C. The asterisks (*) denote the best 
classification possible as adapted from a table in [20].
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Figure 7. Proportions of different genera recovered from dental plaque of healthy adults
Supragingival plaque from a group of 98 healthy individuals by sampling cheek-side dental 
surfaces using a sterile, DNA-free wooden toothpick and stored at −80°C. The asterisks (*) 
denote the best classification possible as adapted from a table in [20].
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Figure 1.4: Comparison of composition of the salivary and periodontal microbiome. V6 sequence data was 
obtained with 454 pyrosequencing of (A) plaque (N=98) and (B) saliva (N= 71) and plaque samples collected from 
healthy adults who had not used antibiotics for at least three months (Keijser et al. 2008). The salivary microbiome 
was dominated by Firmicutes (genus Streptococcus and Veillonella) and Bacteroidetes (genus Prevotella), while the 
supragingival plaque was dominated by Firmicutes and Actinobacteria (genus Corynebacterium and Actinomyces) 
(Keijser et al. 2008). The asterisks (*) denote the best classification possible as adapted from a table in (Keijser et al. 
2008). Figure adapted from (Costalonga & Herzberg 2014).  
 
1.2.3 The oral microbiome in health and disease 
The mouth is the primary gateway through which environmental pathogens gain access to the 
human body. Oral bacteria can gain entrance to the blood stream via the gingival crevice and can 
be the cause of infective endocarditis (Parahitiyawa et al. 2009) and abscesses of the brain (da 
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Silva et al. 2004) and liver (Schiff et al. 2003). In addition to being a reservoir for environmental 
pathogens, the oral microbiome has been identified as a marker of systemic disease. Altered oral 
microbiomes have been observed in individuals with diabetes (Long et al. 2017), bacteraemia 
(Roda et al. 2008), cancer (Michaud & Izard 2014), HIV (Kistler et al. 2018), autoimmune disease 
(Lerner et al. 2016) and systemic inflammation (Hayashi et al. 2010). Distinct oral microbiomes 
have additionally been observed for non-disease states, for example in pregnant and lactating 
women (Zarco et al. 2012), indicating that homeostatic alterations in the body may manifest in 
the oral microbiome. Commensal bacterial communities maintain oral health by occupying 
ecological niches in the oral cavity, preventing colonization by pathogenic bacterial species 
(Vollaard & Clasener 1994). Periodontal disease (PD) occurs when anaerobic bacteria colonize 
the space between the gingivae and teeth, resulting in an inflammatory periodontal pocket.  PD 
is a polymicrobial condition that appears to be initiated by the reduction of commensal bacteria 
and the expansion of pathogenic bacterial communities, as opposed to the presence of a specific 
pathogen. PD is characterised by shifts away from the core oral microbiome and the expansion 
of keystone pathobiont bacterial species, such as Porphyromonas gingivalis and Streptococcus 
mutans (Costalonga & Herzberg 2014). Originally identified using culture-dependent methods, 
bacteria known as the ‘red complex’ (P. gingivalis, Tannerella forsythia and Treponema 
denticolaI) and ‘orange complex’ (Fusobacterium, Prevotella, and Campylobacter species) have 
been associated within progression to periodontal disease and oral inflammation (Hajishengallis 
& Lamont 2012; Socransky et al. 1998). Culture-independent studies have identified a number of 
new species belonging to the Bacteroidetes, Firmicutes, Proteobacteria, Spirochaetes and 
Synergistetes phyla as candidate pathogens associated with PD (Pérez-Chaparro et al. 2014).  
 
Recent NGS has detected low levels of red complex bacteria in 95% of healthy individuals, 
indicating that they form part of the commensal oral bacterial community in the non-diseased 
population (Segata et al. 2012). Takeshita et al.  (2012) identified two distinct community types 
in saliva, the first comprising of predominantly P. histicola, P. melaninogenica, Veillonella parvula, 
V. atypica, S. salivarius, and S. parasanguinis and the second predominantly Neisseria flavescens, 
Haemophilus parainfluenzae, Porphyromonas pasteri, Gemella sanguinis, and Granulicatella 
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adiacens (Takeshita & Yamashita 2012). High bacterial diversity and community composition 
similar to the first group was associated with poor oral health, including PD and tooth decay 
(Yamashita & Takeshita 2017). Like other microbial dysbiosis, More research is required to 
understand the predisposing factors that cause previously commensal bacteria to acquire 
virulence factors and become pathogenic.  
 
1.3 The vaginal microbiome 
1.3.1 Defining a core vaginal microbiome 
Since the first description by Gustav Döderlein in the late 1900s, an optimal vaginal microbiome 
has been understood to be largely dominated by the Lactobacillus genus (Rogosa 1960). 
Lactobacilli are gram-positive, facultative anaerobes that ferment glycogen produced in vaginal 
secretions into D- and L- lactic acid (Witkin et al. 2014). Lactic acid production sustains a low 
vaginal pH (pH 3.5-4.5) that is protective against opportunistic pathogens (Boskey et al. 2014; 
Alakomi et al. 2000) and is believed to stimulate innate host immune factors (Mirmonsef et al. 
2011). Lactobacilli provide the first line of defence against urogenital pathogens by competing 
for nutrients and host cell receptors at the epithelial cell surface (Zarate & Nader-Macias 2006). 
Further, Lactobacilli are believed to provide additional protection against invasive bacterial 
species through the production of bacteriocins and co-aggregation with pathogens, facilitating 
easy clearance of the organisms by host innate immune mechanisms (Boris et al. 1998; Spurbeck 
& Arvidson 2010). The vaginal microbiome is largely shaped by hormonal fluctuations during a 
woman’s lifetime (Gajer et al. 2012). As oestrogen levels rise during puberty, glycogen is 
deposited in the vaginal epithelium supporting Lactobacilli growth and lactic acid fermentation. 
While influenced by a variety of external factors such as vaginal hygiene, sexually transmitted 
infections (STIs) and antibiotic use, lactobacilli dominate the vaginal microbiome of the majority 
of women of reproductive age (Gajer et al. 2012). Unlike other ecological niches within the 
human body, the human vaginal tract is believed to be dominated by one of four major 
Lactobacilli species – L. iners, L. crispatus, L. jensenii or L. gasseri (Ravel et al. 2011; Gajer et al. 
2012).  
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1.3.2 Bacterial vaginosis (BV) 
BV is the most prevalent urogenital disorder of reproductive age women with prevalence ranging 
from 25-50% in different populations (Kenyon et al. 2013). BV is a microbial dysbiosis, 
characterised by a reduction of Lactobacillus communities and an expansion of gram-negative 
and strictly anaerobic bacteria collectively known as BV associated bacteria (BVAB), including 
Gardnerella, Atopobium, Mobiluncus and Prevotella (Swidsinski et al. 2005; Fredricks et al. 2005). 
As a result of the reduction in lactic acid production and increase in proteolytic breakdown of 
amino acids into amines, symptomatic and asymptomatic BV presents as an increase in vaginal 
pH, release of proinflammatory cytokines and vaginal discharge and odour (Masson et al. 2015). 
While BV is not sexually transmitted, it may be sexually-associated or –enhanced, as increased 
numbers of sexual partners have been shown to be to be associated with an increased risk of BV 
(Fethers et al. 2008). The aetiology of BV is not well understood and vaginal douching, smoking, 
menstrual blood, previous HSV-2 infection and lack of condom use have all been identified as 
factors that may increase a woman’s risk of BV (Fethers et al. 2008; Cherpes et al. 2008; Smart et 
al. 2004). While BV often resolves in the absence of any intervention, antibiotic treatment has 
been shown to restore vaginal microbial balance, however, the natural life cycle of BV is not well 
understood and BV re-occurs in 15-60% of women following treatment with antibiotics (Vodstrcil 
et al. 2017; Bradshaw et al. 2006).  
 
Part of the difficulty in investigating the aetiology of BV is due to subjective diagnostic criteria, 
the Amsel criteria, used to identify BV in clinical settings. BV is diagnosed by the presence of at 
least three of the four Amsel criteria: (i) thin white or yellow homogenous vaginal wall discharge, 
(ii) microscopy confirmed presence of clue cells (squamous epithelial cells with adherent 
bacteria), (iii) vaginal pH > 4.5 and (iv) a fishy odour upon adding 10% potassium hydroxide to 
vaginal fluid on a glass slide (Amsel et al. 1983). In laboratory and research settings, BV is 
diagnosed by Nugent scoring (Nugent et al. 1991), which makes use of gram-staining a slide of 
vaginal fluid and scoring the proportion of gram-positive Lactobacilli, smaller gram variable 
curved and rod shaped bacteria. A combined score is calculate to diagnose BV positive (at or 
above seven), BV intermediate (between four to six) and BV negative (three and below) (Nugent 
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et al. 1991). Controversy exists around the reliability of Amsel criteria due to association of 
vaginal discharge and odour with a number of other urogenital disorders, as well as the lack of 
Amsel defined symptoms in up to 50% of BV cases identified by Nugent scoring (Moallaei & 
Namazi 2015). In addition to this, both Amsel criteria and Nugent scoring rely on subjective 
diagnostic criteria and can be influenced by the location and manner of vaginal sampling and the 
individual interpreting the gram stain (Guise et al. 2001). BV has been identified as an 
independent risk factor for the acquisition of STIs including HIV, pelvic inflammatory disease and 
adverse birth outcomes (Leitich et al. 2003; Wiesenfeld et al. 2003; Sweet 1995).  
 
1.3.3 Redefining an optimal vaginal microbiome 
Based largely on North American studies, a ‘healthy’ or ‘normal’ vaginal microbiome is defined 
as one containing predominantly Lactobacillus bacterial commensal species, having a low vaginal 
pH (3.5-4.5), and having no Candida, STI or BV present (Ma et al. 2012; Huang et al. 2015). In a 
study of 296 asymptomatic American women of reproductive-age, Ravel et al. (year) concluded 
that a “healthy” core vaginal microbiome does not exist, and identified five distinct community 
types (CTs) dominated by L. crispatus (26.25%), L. gasseri (6.3%), L. iners (34.1%), L. jensenii 
(5.3%) and non-lactobacilli bacteria (26%) (Ravel et al. 2011). Of the lactobacillus -dominated CTs, 
women with L. crispatus-dominant CTs had the lowest vaginal pH and those with predominantly 
L. iners CTs had the highest. This is in agreement with genomic studies describing protein families 
encoded by different lactobacillus species, indicating that different community compositions may 
confer differing levels of protection to the host (Mendes-soares et al. 2014; Sullivan et al. 2009). 
The vaginal microbiomes of the 26% of women not dominated by Lactobacilli were composed of 
strictly anaerobic bacteria, including Prevotella, Dialister, Atopobium, Gardnerella, Megasphaera, 
Peptoniphilus, Sneathia, Eggerthella, Aerococcus, Finegoldia, and Mobiluncus (Ravel et al. 2011). 
The authors additionally noted that while 80-90% of CTs of White and Asian women were 
dominated by lactobacilli, only ~60% of Hispanic and African-American women had CTs 
dominated predominately by lactobacilli (Ravel et al. 2011). These findings have been confirmed 
by a number of other studies (Fettweis et al. 2014; Zhou et al. 2011), indicating a distinct vaginal 
microbiome in African-American women characterised by high bacterial diversity and low 
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numbers of Lactobacillus, both with and without a clinical BV diagnosis. These studies have 
challenged the paradigm of using Lactobacilli as the marker of a “healthy’ vaginal microbiome 
and high bacterial diversity and presence of BVAB as the marker of a “unhealthy” vaginal 
microbiome (Ma et al. 2012). Our current understanding of the correct microbiome and 
molecular correlates for vaginal health are still incomplete and further research is needed into 
the extent to which host genetics play a role in determining vaginal microbial composition, 
whether there are functional redundancies by which non-lactobacillus bacterial communities 
may facilitate lactic acid fermentation to maintain a protective vaginal microbiota, and whether 
a non-lactobacillus dominated vaginal microbiome is actually a healthy state in some women.  
 
1.4 PD, BV and pre-term birth (PTB) 
Both PD and BV,  conditions characterised by microbial dysbiosis, are associated with a two- to 
four-fold risk of PTB (Pretorius et al. 2007; Harper et al. 2012). PTB, defined as birth before 37 
full weeks of gestation, is the leading cause of infant mortality globally (Liu et al. 2017). Up to 
40% of PTB is thought to be the result of infection that results in either a foetal or maternal 
inflammatory response (Liu et al. 2017). Despite the strong epidemiological evidence for an 
association between BV, PD and PTB, it is unknown whether microbial dysbiosis in the oral and 
vaginal cavity are linked or act as two independent risk factors for PTB (Figure 1.5). Furthermore, 
the difficulty in diagnosing and treating microbial dysbiosis has yielded mixed results of clinical 
trials using PD and BV treatment to reduce adverse birth outcomes (Srinivasan et al. 2009). 
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Figure 1.5: Hypothesized causal pathways underlying the observation association between BV, PD and PTB. During 
pregnancy, microbial dysbiosis in the oral and vaginal tract are thought to initiate a host and/or foetal immune 
response. Bacteria are hypothesized to access the uterine cavity by ascending through the genital tract or via 
systemic entry points, such as the oral cavity, triggering a clinical or subclinical inflammatory cascade that results in 
the release of proinflammatory cytokines and prostaglandins, inducing myometrial contractions and spontaneous 
pre-term birth. It is currently unknown to what extent this is a localized inflammatory response as the result of 
colonization of bacteria from distal sites to the uterine tissue, or a systemic inflammatory response triggered by 
bacterial dysbiosis at distal sites. Additionally, little is known about the extent to which host genetics modulate this 
inflammatory cascade. (Figure adapted from (Srinivasan et al. 2009)) 
 
1.4.1 BV and PTB 
BV during pregnancy has been found to be an independent risk factor for PTB, increasing a 
woman’s likelihood of delivering before term by two- to five-fold (Leitich et al. 2003). BV during 
pregnancy is also associated with an increased risk of low-birth weight, chorioamnionitis and 
premature rupture of amniotic membranes (PROM) (Leitich, Bodner-adler, and Brunbauer 2003). 
Studies investigating the size of the effect of BV on adverse birth outcomes have reported varying 
results, most likely due to the subjectivity in clinical BV diagnostic criteria. In a study including 
221 women, expanding BV diagnosis to include atypical gram-positive bacteria and neutrophils 
on gram-stained vaginal smears was successful in predicting 75% of pre-term birth cases in 
comparison to 25% predicted using traditional Nugent scoring (Verstraelen et al. 2007). BVABs 
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produce proteolytic enzymes (such as sialidase, prolidase, elastase and mucinase) and 
prostaglandin precursors (such a phospholipase 2A) that have been shown to induce preterm 
birth in mice models (Bennett et al. 2000; Celik & Ayar 2002). Increased levels of sialidase activity 
in the vaginal tract are associated with both clinically diagnosed BV and PTB, with 70% of sialidase 
activity being attributed to the presence of BVAB species, such as Prevotella, Bacteriodes and 
Gardnerella (Briselden et al. 1992). In a study of pregnant Danish women, where clinically 
diagnosed BV was not associated with an increased risk of PTB, increased sialidase and/or 
prolidase activity in the genital tract in conjunction with a high vaginal pH was shown to 
significantly increase the risk of both PTB and low-birth weight (Cauci et al. 2005).  
 
In addition to directly triggering a maternal or foetal immune response via accession through the 
genital tract and/or the production of inflammatory by-products in the uterine tissues, BV may 
also act as a marker of other urogenital infections associated with PTB risk (Srinivasan et al. 2009). 
It is hypothesized that increased activity of proteolytic enzymes may degrade the mucosal 
epithelial barrier of the vaginal tract, facilitating STI infections (Srinivasan et al. 2009). BV is 
associated with an increased risk of infection by Neisseria gonorrhoeae, Chlamydia trachomatis 
and HIV (Myer et al. 2005; Wiesenfeld et al. 2003) – STIs that all have been implicated in 
increasing the risk of PTB and other adverse birth outcomes (Dean et al. 2013). It has additionally 
been hypothesized that a lactobacillus-dominant vaginal microbiome may be protective against 
PTB, although trials using lactobacillus vaginal probiotics have been shown to be effective in 
reducing BV recurrence without any impact in reducing adverse birth outcomes (Othman et al. 
2007).  
 
South Africa currently follows a syndromic management approach to STI control where patients 
are treated based on the symptoms with which they present rather than deferring treatment 
until laboratory tests are available (Black et al. 2008). As per the Centre for Disease Control (CDC) 
recommendations clinically diagnosed BV is treated with antibiotics effective against anaerobic 
bacteria, such metronidazole or clindamycin (Centre for Disease Control 2015). Although there is 
no gold standard with regards to the type or dosage of antibiotics used, clindamycin has been 
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shown to be more effective at reducing BVAB populations with the caveat that it reduces 
protective lactobacilli populations at the same time (Lamont 2005). Studies investigating the use 
of BV testing and treatment to reduce adverse birth outcomes have reported mixed results, likely 
due to difference in BV diagnostic criteria and antibiotic treatment administered. A systematic 
review of 13 studies found antibiotic treatment to be effective in treating BV in pregnant women 
but to have no impact on the occurrence of PTB compared to a placebo (Brocklehurst et al. 2013). 
There was no difference in the effect observed when comparing type of antibiotic, route of 
delivery, antibiotic dosage or gestational time at time of treatment (Brocklehurst et al. 2013). 
Only two studies extended the exposure criteria to include women who had both clinically 
diagnosed BV (Nugent score greater than 7) and intermediate bacterial microbiota (Nugent score 
between 4-7)(Lamont et al. 2003; Ugwumadu et al. 2003). When combining the findings of these 
two trials, authors identified a significant reduction in the occurrence of preterm birth in 
pregnant women with abnormal vaginal microbiota (defined as Nugent score greater than 4) who 
received clindamycin treatment in comparison to those who did not (Brocklehurst et al. 2013). It 
is clear from our current knowledge that traditional clinical diagnostic criteria for BV are not 
sufficient in identifying microbial dysbiosis in the genital tract and that our current understanding 
of what constitutes a “healthy’ vaginal microbiome may not be the case for certain generalisable 
to all women. 
 
1.4.2 PD and PTB 
The association between PD and PTB was first described by Offenbacher et al. (1996) in a case-
control study where antepartum moderate-severe PD was found to increase the risk for 
spontaneous PTB two-fold (adjusted risk ratio (RR): 2.4, 95% CI)). Ten years later, a systematic 
review identified twenty-two observational studies (N participants= 7152) investigating the 
relationship between PD and negative birth outcomes. Of these studies, eighteen reported 
findings that PD was linked to increased risk of PTB, LBW babies (defined as a birth weight of less 
than 2500g) and PROM, while eight studies found no evidence of an association (Xiong et al. 
2006). Meta-analyses of these studies indicated a positive association between PD and PTB 
and/or LBW (pooled odd ratio: 2.83; 95% CI: 1.95-4.10), but authors noted lower associations in 
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higher quality studies and recommended that the relationship be confirmed by larger 
randomised multi-centre trials (Vergnes & Sixou 2007). Of the seventeen studies in this 
metanalysis, only three assessed the microbial composition of the oral microbiota to diagnose 
PD. For those where microbial analysis was not done, a range of diagnostic criteria – including 
clinical attachment loss, bleeding on probing, plaque index, gingival index and dental mobility, 
were used to assign PD status (Vergnes & Sixou 2007). Clinical trials assessing the treatment of 
PD treatment during pregnancy to prevent adverse birth outcomes have reported mixed results  
(Iheozor-Ejiofor et al. 2017). A recent systematic review of 15 studies including 7161 participants 
noted that in addition to heterogeneity in PD diagnostic criteria, a number of different PD 
interventions were used, ranging from dental hygiene education to surgical and non-surgical 
therapies (Iheozor-Ejiofor et al. 2017). Authors identified a high risk of bias in all of the studies 
and concluded that there is a lack of quality evidence for the effectiveness of PD treatment to 
reduce PTB and other adverse birth outcomes (Iheozor-Ejiofor et al. 2017).  
 
Although PD affects up to 50% of women in some populations, it is believed that hormonal shifts 
during pregnancy, specifically increases in progestogen levels, result in an increased incidence of 
PD in pregnant women (Figuero et al. 2013). The levels of PD-associated oral bacteria, including 
P. gingivalis, T. forsythia, P. intermedia, and P. nigrescens, were found to be significantly 
increased by at least two-fold in the oral cavity of women who had delivered pre-term compared 
to those who had not (Lin et al. 2007). The most commonly accepted hypothesis for the causal 
relationship between PD and PTB describes the hematogenous dissemination of inflammatory 
products released by red and orange complex bacteria in the oral cavity, resulting in a systemic 
inflammatory response that initiates uterine contractions and PTB (Pretorius et al. 2007). This 
has been supported by a number of studies identifying increased levels of inflammatory 
cytokines, such as IL1-b and PGE2, in the gingival crevicular fluid of women who deliver pre-term 
and/or LBW babies compared to those who delivered to term (Konopka et al. 2003; Offenbacher 
et al. 1998). In studies investigating the relationship between PD and cardiovascular disease, PD 
has been found to be associated with serological markers of systemic inflammation including 
increased levels of C-reactive proteins (CRP) and IL-6 (Amar et al. 2003; D’Aiuto et al. 2004). Few 
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studies have investigated the association between PD, systemic inflammation and adverse birth 
outcomes but one study found that pregnant women with both PD and increased systemic CRP 
were at a higher risk of developing preeclampsia compared to women without PD and both low 
and high levels of systemic CRP (Ruma et al. 2008). Based on identification of known oral 
pathogens such a Fusobacterium in the amniotic fluid of women who delivered pre-term and the 
absence thereof in term births (Hill 1998), it has been suggested that oral pathogens themselves 
may migrate to the uterine tract, causing decidual and chorioamniotic infections (Pretorius et al. 
2007), although the exact mechanism through which this happens has yet to be elucidated 
 
The mechanisms through which PD-associated bacteria might migrate to the genital tract and 
increase the risk of PTB through systemic infection is currently unclear, although invasive dental 
procedures and daily activities such as teeth brushing are thought to induce temporary 
bacteraemia that may create an opportunity for invasive bacteria to enter the blood stream 
(Toma et al. 2012; Forner et al. 2006). Additionally, both foetal and maternal immune responses 
seem to play a large role in determining the extent to which PD-associated oral bacteria impact 
adverse birth outcomes. In a study that found no significant differences in the levels of oral PD-
associated bacteria between mothers who gave birth pre-term and at term, cord blood of 
preterm infants was found to have significantly higher rates of IgM seropositivity to bacteria 
belonging to the PD-associated red and orange cluster bacteria in comparison to infants born at 
term (Madianos et al. 2003). The same study found a lack of maternal IgG antibodies to red-
cluster bacteria to be associated with 2.2-fold increased odds of PTB (Madianos et al. 2003). 
Subsequent studies have found foetal inflammation to be a modifier of the foetal immune 
response, with high cord blood IgM responses in conjunction with high levels of foetal 
inflammatory cytokines and CRPs to confer a greater risk of PTB compared to strong IgM 
responses alone (Boggess et al. 2005). While the protective effect of maternal IgG antibodies was 
observed in another study of African-American women (Dasanayake et al. 2003), a study of 
Hispanic women found no association between maternal IgM and PTB risk (Jarjoura et al. 2005), 
indicating that host genetics may play a role in mediating the immunological interaction between 
PD and PTB.  
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1.4.3 Evidence for a relationship between PD and BV 
Although there is a large body of work investigating the independent association of BV and PD 
with PTB, the combined effect of microbial dysbiosis in the vaginal and oral microbiome has not 
been extensively studied. In the United States, PTB only occurs in around 12% of births (Martin 
et al. 2007), although the prevalence of BV and PD in pregnant women are thought to be 
approximately 15% and 50%, respectively (Vogt et al. 2012; Hillier et al. 1995). In a cohort study 
of 3569 non-pregnant women (80% of whom were African-American), the prevalence of BV and 
PD were 40% and 26%, respectively, and 12% of women had both BV and PD simultaneously, 
translating into 1.29-fold (95% CI: 1.13-1.47) greater risk of PD among women with BV. In a study 
of 180 non-pregnant women with a clinically-diagnosed BV prevalence of 27.2%, BV positive 
women were significantly more likely to have gingivitis (a reversible inflammatory condition of 
keratinized and non-keratinized gum tissues surrounding the teeth as a results of biofilm 
formation of PD_-associated bacteria) compared to BV negative women (Persson et al. 2009). 
Irrespective of clinically-diagnosed BV status, women with gingivitis were found to have 
significantly increased counts of BVAB, such as P. bivia and P. disiens, in their genital tracts 
(Persson et al. 2009). Similarly, women with both BV and gingivitis had higher counts of PD-
associated bacteria in their genital tracts, including P. gingivalis, T. forsythia and Fusobacterium 
species (Persson et al. 2009). Cassini et al. (2013) directly investigated the synergistic relationship 
of PD and BV in pregnancy. In a cohort of 792 pregnant women, the prevalence of clinically-
diagnosed BV and PD was 55% and 53%, respectively (Cassini et al. 2013). The prevalence of PD 
in women with a clinical BV diagnosis was 70% compared to a PD prevalence of 34% in women 
without BV (Cassini et al. 2013). This study found that neither BV alone, PD alone or both PD and 
BV together were associated with an increased risk of PTB or adverse birth outcomes (Cassini et 
al. 2013).  
 
There is evidence for a hereditary component for PTB risk, with the risk of PTB found to be higher 
in women who were born preterm (Flint Porter et al. 1997), having a sibling born pre-term 
(Winkvist et al. 1998), or having a female family relative who experiences a preterm birth (Mercer 
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et al. 1999). A number of studies have identified genetic polymorphisms that are associated with 
an increased risk of PTB relating to the production of pro- and anti-inflammatory cytokines, 
including increased production of TNF-alpha and IL-6 and decreased production of IL-10, as well 
as innate defence factors such a toll-like receptors and metalloproteinases, (reviewed by 
Srinivasan et al. 2009). A number of alleles of inflammation-related genes  have been associated 
with a predisposition towards PD and/or BV, (Srinivasan et al. 2009; Pretorius et al. 2007). There 
is additionally evidence for population-specific differences regarding genetically determined 
inflammatory responses, with reports indicating elevated IL-6 production to be associated with 
PTB in Caucasian women but not Africa-American women (Menon et al. 2008). In the same 
population of women with PTB cases, increased IL-6 production was observed in Caucasians and 
increased IL-1B was observed in African-Americans (Menon et al. 2007). Additionally, 
polymorphisms for maternal IL-12 and foetal IL-12B production were identified as PTB risk factors 
in a study assessing PTB risk factors in African -American women (Velez et al. 2009). This has led 
to the hypothesis that the association between PD, BV and PTB may be modulated by host 
genetics that may influence susceptibility to colonization by anaerobic bacteria, as well as 
mounting a maternal and/or foetal inflammatory immune reaction in response to microbial 
dysbiosis. While the mechanism through which PD initiates PTB via systemic inflammation or 
systemic infection is speculative, both maternal and foetal factors are likely involved. 
 
1.5 Oral and vaginal microbiome of the South African population 
Young women are disproportionately affected by HIV in Sub-Saharan Africa (Cowan & Pettifor 
2009). Almost half of all new HIV infections occur in women under the age of 25, and HIV infection 
rates are up to eight times as high in women aged 15-24 compared to in men of the same age 
group (Cowan & Pettifor 2009). While high-risk sexual networks and sexual risk behaviours place 
adolescent women at high risk of HIV exposure, this alone cannot explain their increased risk of 
HIV acquisition (Katz & Low-Beer 2008; Pettifor et al. 2011). Evidence suggests that biological 
factors, such as a high prevalence of vaginal microbial dysbiosis, may contribute to the 
disproportionate rates of HIV acquisition amongst these adolescent females (Jaspan 2011). In 
addition to the risk of HIV acquisition, young women in South Africa are also at a high risk of 
 30 
pregnancy, with 30% of 15-19 year olds reporting having ever been pregnant (Panday et al. 2009). 
Young women are also more at risk for adverse birth outcomes such as preterm delivery and 
small for gestational age infant (Khashan et al. 2010). Recent studies in young South African 
women have described vaginal microbiota characterised by low lactobacilli abundance, high 
bacterial diversity, a high prevalence of BV and a higher vaginal pH in comparison to their North 
American counterparts (Lennard et al. 2018; Anahtar et al. 2015). Anahtar et al. (2015) identified 
four distinct vaginal CTs in young HIV-negative South African women: three dominated by non-L. 
iners Lactobacilli, L. iners Lactobacilli, and Gardnerella, respectively, and one mixed CT. This study 
found bacterial diversity and the presence of specific bacteria including Fusobacterium, 
Aerococcus, Sneathia, Gemella, Mobiluncus, and Prevotella, to be associated with increased 
concentrations of pro-inflammatory cytokines in the genital tract (Anahtar et al. 2015). Previous 
work by our group in Cape Town, in the same study population that this study is based, identified 
three distinct vaginal CTs in these young South African women: two dominated by L. iners, or L. 
crispatus, respectively, and a third comprised of diverse BVAB, which was associated with high 
genital tract inflammation and persistent BV infection (Nugent score > 9; Lennard et al. 2018). In 
agreement with the previous study, the presence of certain BVABs, including Prevotella, 
Sneathia, Aerococcus, Fusobacterium and Gemella, were associated with genital tract 
inflammation (Lennard et al. 2018).  
 
To my knowledge, there have been no studies characterizing the South African oral microbiome. 
Additionally, there are currently no studies investigating the epidemiological or causal interaction 
between PD and BV in South Africa women, despite the high prevalence of BV in this population. 
Young South African women are at a high risk for both, HIV infection and adverse birth outcomes, 
both of which are associated with shifts away from healthy oral and vaginal microbiomes, 
however current knowledge of what constitutes a healthy microbiome is largely based on North 
American studies. Based on the marked differences in the composition of the vaginal microbiome 
in young South African women and their north American counterparts, more research is required 
to better understand the interaction between microbial dysbiosis and preterm birth in this 
population.  
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CHAPTER TWO: Aims & Objectives 
Aim: This study aims to characterise the oral and vaginal microbiome of South African female 
adolescents in order to investigate the association between bacterial vaginosis and periodontal 
disease.  
Specific Objectives:  
1. Characterisation of the oral and vaginal microbiome of South African adolescent females. 
Shifts away from healthy oral and vaginal microbial populations are associated with a number of 
adverse health outcomes that are prevalent in young South African women, however current 
knowledge of what constitutes a healthy microbiome are largely based on North American 
studies. To the best of our knowledge, no study has described the oral and vaginal microbiome 
of South African adolescent females using next-generation sequencing methods.  
2. Investigate the association between alterations oral bacterial diversity and BV in young 
South African women  
Previous data from our group suggests abnormal vaginal flora may be common in African 
adolescents, the group most at risk for HIV infection and teenage pregnancy. Dysbiosis in healthy 
oral and vaginal microbiomes is associated with negative reproductive health outcomes in 
women yet it is unknown whether PD and BV are independent risk factors or may be interrelated. 
Understanding the health risks associated with pregnancies in young women is critical for 
developing new preventative intervention and for informing guidelines.  
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CHAPTER THREE: Materials and Methods 
3.1 Sample Collection 
3.1.1 Study Cohort 
 
For the purpose of this study, samples were obtained from the previously approved UChoose-A-
Star (HREC REF 801/2014) sub-study, where participants were drawn from the pre-existing NIH 
funded parent study “Choices For Adolescent Prevention Methods for South Africa (CHAMPS): 
An Open-Label, Randomized Crossover Study to Evaluate the Acceptability and Feasibility of, and 
Adherence to, Contraceptive Choices” (R01AI094586; PI Prof Linda-Gail Bekker). The CHAMPs 
study investigated the acceptability and preference for contraceptive options in South African 
female adolescents, as proxy for HIV prevention methods. CHAMPS enrolled 150 healthy HIV-
negative females age 15-19 years attending the Desmond Tutu HIV Foundation (DTHF) Youth 
Centre in Masiphumelele, Cape Town, South Africa. The UChoose-A-Star sub-study utilised the 
infrastructure of the CHAMPs study to investigate hormone-induced mucosal changes and HIV 
susceptibility in South African adolescents. For the purpose of this study, samples from 75 
adolescent girls with (N = 35) and without (N = 40) bacterial vaginosis, HIV-negative, non-
pregnant females aged 15 to 19 enrolled in the UChoose-A-Star study were included. The 
collection of all samples utilised in this study was previously approved by the University of Cape 
Town Human Research Ethics Council as part of the U-Choose-a-Star study protocol. Oral and 
vaginal samples are collected at the screening visit. No additional samples were collected for the 
purpose of this study. Additional eligibility criteria for the parent study included: contraceptive 
naïve or wish for a method change, no symptomatic STI within the prior 40 days, negative urine 
pregnancy test and no intent to be pregnant in the next 8 months, no contraindications to any 
study product, and willing to refrain from inserting any non-study vaginal products or objects into 
the vagina throughout the duration of study participation, willing to use condoms for anal and 
vaginal sex.  
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3.1.2 Ethical issues and risk assessment 
All aspects of the parent study were conducted according to the International Conference on 
Harmonization (ICH) Good Clinical Practices (GCP), and with approval by all relevant Institutional 
Review Boards (IRB) in Cape Town and the USA. In addition, this study complied with the South 
African National Health Act (NHA, No. 61, 2003) and the South African Good Clinical Practice 
Guidelines (DOH 2006). Prior to enrolling participants in the study cohort, the parent study 
underwent ethical review and was approved by each academic institution and medical clinic 
where the proposed work was carried out. All samples used in this sub-study are deidentified.  
 
For both the CHAMPS parent study and UChoose sub-study, consent was required from a parent 
or guardian, as well as assent from those <18 years. Although South African adolescents from age 
12 years and older are allowed to consent to contraceptives and contraceptive advice 
independently in terms of the Children’s Act (No. 38 of 2005), at present the South African 
National Health Act states that any health research on minors requires parental or guardian 
consent. The consent form(s) described the study in detail, including the purpose, study 
procedures, duration and frequency of visits, types of information and specimens to be collected, 
potential risks and benefits (if any) of study participation, and alternatives to study participation. 
Informed consent was obtained in the adolescent’s preferred language. If participants were 
under the age of 18, consent from one parent was obtained in accordance with the South African 
Children’s Act [No. 38 of 2005], Chapter 3, Part 20, and with US DHHS Human Subjects Research 
CFR 46.404. The consent forms were updated as necessary to reflect protocol revisions or new 
information. If an independent witness was necessary due to illiteracy, the witness was required 
to sign stating the process was adequately explained and the guardian fully understood. Original 
signed consent documents have been maintained in secure files. If the adolescent turn 18 years 
during the study, she signed the participant consent form. 
 
A variety of mechanisms have been established to protect the confidentiality of medical records 
and data procured in this research. Databases are password protected, a unique study ID number 
was assigned at the beginning of the study and this number was used as the indirect identifier in 
databases and lab specimens. Patient privacy was maintained and this was communicated to the 
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study participants. All data was confidential, except STI and HIV results for referral clinicians only 
if necessary. Other results were coded, and kept under lock and key. Results of hormonal testing 
was not be made available to the adolescent unless they were of clinical consequence (for 
example if it became obvious she was not adherent to medication). Likewise, none of the 
microbiome analysis (except clinically relevant BV) or cervical immunology was discussed with 
the adolescent or their guardian. The consent and assent forms clearly stipulated that the results 
of the adolescents’ STI and HIV test results would not be available for the legal guardian but that 
it was up to the adolescent to disclose results to a responsible adult, therefore results were only 
disclosed to the adolescent. Support was provided for such disclosures. The consent also clearly 
stated the conditions under which a breach of confidentiality is required according to the 
Children’s Act (No. 38 of 2005) including knowledge of sexual abuse. The age of consensual sex 
is 16 years, and therefore underage sex is not an issue in this protocol (Teddy Bear Clinic for 
Abused Children, and Prevention of Child Abuse and Neglect (RAPCAN) V Minister Of Justice And 
Constitutional Development Case (Case Number 73300/10). 
 
3.1.3 Oral and vaginal sample collection 
 
Clinical samples for oral and vaginal microbiome analysis and STI testing were collected at the 
screening visit by clinicians at the Desmond Tutu HIV Youth Centre Clinic, Masiphumelele. 
Samples were then transported to the University of Cape Town, processed and placed into 
storage on the same day of collection. These samples include: a vulvo-vaginal swab for STI testing, 
a posterior fornix and lateral wall swab for bacterial vaginosis testing, a vaginal lateral wall swab 
for vaginal microbiome analysis, and periodontal fluid and a saliva specimen for oral microbiome 
analysis. With the exception of bacterial vaginosis (BV) and STI testing, all downstream sample 
processing was performed at the University of Cape Town.  
 
3.1.3.1 Oral sample collection 
 
Studies have identified distinct microbial communities existing in different environmental niches 
within the oral cavity (Zaura et al. 2009; Massimo Costalonga & Herzberg 2014). For the purpose 
of this study, two oral samples were collected in order to sample both the periodontal and 
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salivary bacterial composition. Participants were required to have refrained from eating or 
drinking anything other than water for at least 30 minutes prior to oral sample collection. Sterile 
toothpicks were used to scrape and collect supragingival plaque. Immediately after sampling, 
toothpicks were placed into an eppendorf tube with 500μl Tris-EDTA buffer (10 mM Tris HCl, 1 
mM EDTA; pH 8.0) and cut. The eppendorf tube was stored upright at room temperature during 
transport. Saliva samples were collected using the Salivette®(Sarstedt) collection device (Figure 
2.1). All handling of the swab was performed with sterile gloves. Participants were required to 
chew the swab from the Salivette for 60 seconds in order to stimulate saliva production. The 
swab was then spit back into the collection tube and stored upright at 40C during transport. 
Figure 2.1: Instruction of saliva sample collection using the Salivette (Sarstedt) collection device. Edited from 
Salivette®: Hygienic saliva collection for diagnostics and monitoring, Sarstedt. Accessed online at: 
https://www.sarstedt.com/fileadmin/user_upload/99_Broschueren/Englisch/156_Salivette_GB_0813.pdf 
 
3.1.3.2 Vaginal sample collection 
 
Vaginal samples were collected at least 3-4 days after the end of a current menstrual cycle. 
Participants were instructed not to use spermicidal cream or gel for 2 days and to refrain from 
vaginal intercourse, douching, or inserting anything into the vagina for 1 day prior to collection 
of the sample. Vaginal samples were collected from different compartments of the vaginal tract 
as demonstrated in Figure 2.1 after the insertion of a gynaecological speculum. The vulvovaginal 
swab was collected by inserting a DryswabTM Standard Tip Polyester (Medical Wire & Equipment, 
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MW102D) into the vagina and sampling the entire vulval area, the vaginal introitus and the lower 
vagina. A flocked swab (MDG diagnostics) was used to sample the right and left vaginal walls for 
bacterial vaginosis testing. The flocked swab was rolled onto a pH Fix 2.0-9.0 (Macherey-Nagel) 
testing strip and vaginal pH was recorded according to manufacturer’s specifications. The same 
swab was then rolled onto a frosted glass slide and both the swab and glass slide were 
transported for further processing at room temperature. Lateral vaginal wall samples for vaginal 
microbiome analysis were collected using a Digene® Female Swab Specimen Collection Kit 
(Qiagen) according to the manufacturers specifications. All vaginal samples were transported at 
room temperature.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Demonstration of vaginal samples collection after the insertion of a gynaecological speculum. Three 
vaginal samples were collected: (1) a vulvo-vaginal swab for STI testing, (2) a posterior fornix and lateral wall swab 
for bacterial vaginosis testing and (3)a vaginal lateral wall swab for vaginal microbiome analysis, 
 
 
3.2 STI testing 
 
(1) 
(2) 
(3) 
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Vulvovaginal swabs and heat fixed posterior fornix/lateral wall slides were transported at -80O C 
to the National Institute of Communicable Disease (NICD) in Johannesburg, South Africa where 
polymerase chain reaction (PCR) testing for N. gonorrhoea, C. trachomatis, T. vaginalis and M. 
genitalium was performed as described by Lewis et al. (Lewis et al. 2012). Bacterial vaginosis 
status was determined by gram staining and Nugent scoring according to conventional protocols 
(Verstraelen & Verhelst 2009).  
 
3.3 16S rRNA gene V4 DNA extraction and amplification 
A previously optimised DNA extraction protocol had been developed for the extraction of DNA 
for sequencing of the hypervariable V4 16S DNA region from vaginal samples stored at -80OC 
(Lennard et al. 2018). Initially, this protocol and was used for DNA extraction from both stored 
oral and vaginal samples. During the course of this project, this protocol was optimised to amplify 
DNA extraction from oral samples found to have significantly lower DNA yields in comparison to 
the vaginal samples. This optimisation involved of the comparison of various oral sample 
collection and storage methods and the comparison of two commercial DNA extraction kits. For 
each optimization experiment the same overall DNA extraction and quantification protocol was 
followed. Briefly, stored samples were thawed and subjected to mechanical and chemical lysis 
prior to DNA extraction. Extracted 16S rRNA gene DNA was quantified using fluorescence, 
visualised and quality checked using PCR amplification and gel electrophoresis, before storage at 
- 20 OC. Section 3.3.1 describes the previously validated DNA extraction and quantification 
protocol and Section 3.3.2 describes various optimization experiments run to optimise the 
protocol for the extraction of sufficient bacterial DNA from oral samples for amplification of the 
V4 16S rRNA gene region.  
 
 
3.3.1 Previously validated 16S rRNA gene V4 DNA extraction and validation protocol 
3.3.1.1 Sample processing and storage 
 
Samples were transported to the University of Cape Town on the same day of collection. 
Posterior fornix/lateral wall swabs, lateral wall swabs and vulvovaginal swabs were stored at -
800C without further processing. Glass slides were heat fixed and stored at room temperature. 
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Periodontal samples were vortexed and the toothpicks discarded prior to storage at -800C. 
Salivette®(Sarstedt) tubes were centrifuged at room temperature for 5 minutes at 4000 rpm. The 
salivette swab was discarded and the saliva filtrate was transferred into a 2mL cryovial prior to 
storage at -800C.  
 
3.3.1.2 Enzyme digestion 
Bacterial DNA extraction methods can result in preferential sampling of gram negative bacteria, 
as DNA is not as easily released from gram positive bacteria with thick peptidoglycan cell walls 
(Yuan et al. 2012). Enzymatic digestion prior to DNA extraction ensures the rupture of gram 
positive cells walls, resulting in a more representative extraction of  bacterial DNA present in the 
sample(Gill et al. 2016). A number of naturally occurring enzymes can be used to achieve this 
purpose: lysozyme hydrolyzes the β(1→4) linkages between N-acetylmuramic acid and N-acetyl-
D-glucosamine residues in peptidoglycan, mutanolysin cleaves the β-N-acetylmuramyl-(1→4)-N-
acetylglucosamine linkage of the bacterial cell wall peptidoglycan-polysaccharide (Yokogawa et 
al. 1974) and lysostaphin cleaves the polyglycine cross-links in peptidoglycan(Freire et al. 2010). 
Prior to DNA extraction, samples were removed from -80°C storage and thawed on ice. Thawed 
samples were briefly vortexed and 500μl of sample was removed for DNA extraction. An enzyme 
digestion mastermix containing; 50μl 1X Lysozyme from chicken egg white (Sigma-Aldrich, Cat. 
No. L6876), 6μl Mutanolysin from Streptomyces globisporu ATCC 21553 (Sigma Aldrich, Cat. No. 
M9901)and 3μl Lysostaphin from  Staphylococcus staphylolyticus (Sigma Aldrich, Cat. No. L7386) 
was added to each sample and mixed by pipetting.  Samples were incubated at 37°C for 60 
minutes and vortexed every 20 minutes.  
 
3.3.1.3 DNA extraction 
DNA extraction from stored periodontal and saliva samples was initially performed using the 
PowersoilTM DNA Isolation Kit (MoBio) as was done in a previously validated protocol(Lennard et 
al. 2018). A negative extraction control was included where 500 μl of DNase free H2O was used 
in the place of clinical samples. The manufacturer’s instructions were followed with slight 
modifications as follows: All centrifugation steps were carried out using a microcentrifuge at 
10 000g. After enzyme digestion as described in 3.3.1.2, 500μl of sample was added to the 
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provided PowerBead Tubes in addition to 60μL of Solution C1 and vortexed to mix. The 
PowerBead Tubes were then homogenized using the Thermo Savant FastPrepÒ 120 Cell 
Disrupter System (Thermo Savant) for 3 rounds of 30 seconds at 5.5 m/sec. Samples were then 
centrifuged for 30 seconds at room temperature. After 500μl of supernatant was transferred to 
a clean collection tube, 250μl of Solution C2 was added, samples were vortexed and incubated 
for 5 minutes at 4OC.  Following a 1 minute centrifugation, 600μl of supernatant was transferred 
to a clean collection tube and 200μl of Solution C3 was added. Samples were then incubated and 
centrifuged as in the previous step and supernatant was transferred into a clean collection tube. 
Solution C4 was added to make up a final volume of 1750μl and 675μl of this mixture was loaded 
onto the Spin Filter and centrifuged for 1 minute. The filtrate was discarded and this step was 
repeated until all of the mixture from the previous step had been passed through the filter. The 
filter was then washed using 500μl of Solution C5 and centrifuged for 30 seconds. The filtrate 
was discarded and the Spin Filter was centrifuged for 1 minute to remove any residual C5. The 
Spin Filter was then transferred into a clean collection tube and 50μl of Solution C6 (heated to 60 
O C) was added directly onto the filter membrane and centrifuged for 1 minute. This step was 
repeated using another 50μl of Solution C6 resulting in eluted DNA in a final volume of 100μl. 
Extracted DNA was stored at -20 O C for downstream processing. 
 
3.3.1.4 DNA quantification 
 
The dsDNA sample concentration was quantified using the Quant-iTTM High-Sensitivity DNA 
Assay Kit (Invitrogen) and Qubit 2.0 Fluorometer (Invitrogen) according to the manufacturer’s 
instructions. As the reagents used in this kit are light sensitive, all steps of this protocol were 
carried out in the dark where possible. Assays were mixed in thin-wall, clear, 0.5 ml PCR tubes. 
The manufacturers protocol was followed. Briefly, the Qubit® dsDNA HS Reagent and Buffer were 
brought to room temperature and a working solution was created by diluting the Qubit® dsDNA 
HS Reagent 1:200 in Qubit® dsDNA HS Buffer. The required amount of working solution was 
prepared in plastic conical tubes and wrapped in tinfoil to protect from light. Standards were 
created using the supplied Qubit® dsDNA HS Standards and the working solution to make up 
200μl standards with reagent concentrations of 0 ng/μl and 10 ng/μl. Extracted DNA (2μl) was 
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added to 198μl of working solution to make up 200 μl assays that were subsequently vortexed 
and incubated at room temperature for 2 minutes. For each DNA quantification, new standards 
were created and read using the Qubit® 2.0 Fluorometer to generate a double-stranded DNA 
standard curve used to calculate the DNA concentration of the subsequent sample assays.  
Sample assays were read using the Qubit® 2.0 Fluorometer and each assay was vortexed prior to 
reading. The Qubit® 2.0 Fluorometer displays DNA concentration in ng/ml and the following 
formula was used to calculate the concentration of the sample: 
Sample concentration = Qubit value x  !""# , where x = the number of microliters of sample added 
to the assay tube. 
 
3.3.1.5 V4 16S PCR amplification and gel electrophoresis 
Extracted DNA was removed from -20OC storage and thawed on ice. The V4 hypervariable region 
of the bacterial 16S rRNA genes was amplified using PCR according to the following protocol. A 
master mix was created containing: 1μl (5μM/μl) each of the universal forward and reverse 
primers 515F (5’-GTGCCAGCMGCCGCGGTAA-3’) and 806R (5’-GGACTACHVGGGTWTCTAAT-3’) 
and 12.5μl high  fidelity DNA  polymerase KAPA Hotstart Mix (Thermo Scientific™ Phusion™). 
Variable amounts of template DNA were added (maximum volume 10μl) to reach a final amount 
of ~20ng. Variable amounts of DNase free H2O were then added to reach a final reaction volume 
of 25μL per sample (Table 2.1). PCR reaction were run in 0.5-mL PCR tubes using the GeneAmp® 
PCR System 9700 according to the following program: 1 cycle 95°C for 3 minutes, 35 cycles of; 
95°C for 30 seconds, 55°C for 30 seconds and 72°C for 30 seconds, 1 cycle of 72°C for 5 minutes 
hold at 4°C (Table 2.2). All PCRs were run using a  negative control where 10μL of DNase free H2O 
was substituted for sample in the above described mastermix. 
 
The size and quality of each amplified DNA sample was visualised using gel electrophoresis. 2μL 
of amplicon mixed with 0.5ul of 6X TriTrack DNA Loading Dye (Thermo Scientific) was run on a 
1.2% agarose gel (Tris–Acetate–EDTA (TAE) buffer, 90 V,  60 min) with GelRedTM Nucleic Acid Gel 
Stain (Biotium) added to the molten agarose at a dilution of 1:10 000 according to manufacturer’s 
instructions. Either the Gene Ruler 1Kb or O’Gene Ruler 100bp Plus DNA Ladders (both Thermo 
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Scientific) were included at 0.5μg/ml for DNA band size estimation. Successful amplification was 
determined by the presence of a clear band (~320bp).  
 
Table 2.1: Reagent list for validation PCR  Table 2.2: Thermocycler protocol for validation PCR 
Reagent Amount to add  PCR phase Duration/temperature 
Template DNA Max 10μl (to ~20ng DNA)  Initial denaturation 95°C for 3 minutes 
Forward primer 1μl  Cycles (x35)  
Reverse primer 1μl      Denaturation 95°C for 30 seconds 
KAPA Hotstart Mix 12.5μl      Annealing 55°C for 30 seconds 
PCR H2O 0.5μl (up to final volume of 25μl)      Elongation 72°C for 30 seconds 
Total volume: 25μl  Final Elongation 72°C for 30 seconds 
   Storage 4°C 
 
 
3.3.2 Optimization of of 16S rRNA gene V4 region DNA extraction and validation protocol 
3.3.2.1 Optimization Experiment 1: DNA extraction from stored oral samples  
We first investigated the effectiveness of a DNA extraction protocol optimised for DNA extraction 
from vaginal lateral wall samples stored at -80°C on periodontal and saliva samples stored under 
identical conditions. Saliva and periodontal samples were collected and processed as described 
in 3.1. DNA was extracted following the protocol described in 3.3.1.3 using the PowersoilTM DNA 
Isolation Kit (MoBio). Extracted DNA  was quantified using the Quant-iTTM High-Sensitivity DNA 
Assay Kit (Invitrogen) and Qubit 2.0 Fluorometer (Invitrogen) as described in 3.3.1.4. Extracted 
DNA was then amplified using PCR and gel electrophoresis was performed as described in 3.3.1.5. 
DNA quantification revealed all samples to have below detectable concentrations of dsDNA 
(<0.05ng/μl). Gel electrophoresis (Experiment 1, Figure 2.3) revealed no DNA amplicons of the 
expected size (~450 bp) and a high concentration of small genomic bands (<100bp), most likely 
to be primer dimers. These results indicated that the previously validated protocol was not 
effective in extracting DNA from stored periodontal and saliva samples.  
 
 
 42 
 
Figure 2.3: Gel electrophoresis of amplified 16S V4 DNA extracted from stored oral samples using the PowersoilTM 
DNA Isolation Kit (MoBio). Gel electrophoresis was carried out as described in 3.3.1.5. O’Gene Ruler 100bp Plus DNA 
Ladder (Thermo Scientific) was included at 0.5μg/ml in the left most lane for DNA band size estimation. Lanes 2-6 
contain amplicon products after PCR amplification of extracted stored saliva samples. Lanes 7-10 contain amplicon 
products after PCR amplification of extracted stored periodontal samples. Lane 11 and 12 contain negative PCR and 
DNA extraction controls respectively.  
 
3.3.2.2 Optimization Experiment 2: DNA extraction from fresh oral samples with additional 
processing prior to DNA extraction 
We next investigated the effectiveness of a DNA extraction protocol optimised for stored vaginal 
lateral wall samples on fresh periodontal and saliva samples. Saliva gland secretions are thought 
to contain nucleases and proteins that may degrade DNA during extended sample storage and 
inhibit DNA amplification using PCR.  Boiling saliva samples prior to DNA extraction and PCR 
amplification has been observed to result in increased yields of amplified DNA (Ochert et al. 
1994). We therefore added the following to the processing of periodontal and saliva samples: 
(1) Boiling of periodontal and saliva samples prior to extraction in order to deactivate 
potential inhibitors that may be interfering with DNA extraction and PCR reactions 
(2) Concentration of salivary bacteria and removal of the majority salivary supernatant in 
order to eliminate potential inhibitors that may be interfering with DNA extraction and 
PCR reactions 
Periodontal and saliva samples were collected as described in 1.2.1 from volunteers at the 
University of Cape Town. Saliva filtrate was transferred from the Salivette tube as described in 
2.1.1. Saliva samples were then centrifuged for 15 minute centrifugation at 4000g at 4°C. Leaving 
100μl to prevent excluding low-weight bacteria still present in the saliva, saliva supernatant was 
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removed and stored at -800C. The pellet was resuspended in the remaining 100μl of supernatant 
and 300μl Tris-EDTA (pH 8.0)  buffer. The resuspended saliva pellets and periodontal samples 
were then boiled at 95°C from ten minutes. Samples were allowed to cool to room temperature 
prior to extraction. DNA was extracted following the protocol described in 3.3.1.3 using the 
PowersoilTM DNA Isolation Kit (MoBio). In addition to  previously described negative extraction 
control, a positive extraction control containing a stored vaginal lateral wall swab (collected and 
processed as described in 3.1) was included to assess the effectiveness of the previously validated 
DNA extraction protocol.   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
DNA  was quantified using the Quant-iTTM High-Sensitivity DNA Assay Kit (Invitrogen) and Qubit 
2.0 Fluorometer (Invitrogen) as described in 3.3.1.4. Extracted DNA was then amplified using PCR 
and gel electrophoresis was performed as described in 3.3.1.5. DNA quantification revealed 50% 
of the extracted oral samples to have DNA concentration lower than the detectable range (Table 
3). The yield of DNA extracted from oral samples where DNA was detectable was lower than the 
DNA extracted from a stored lateral vaginal wall sample (Table 2.3). The DNA extraction negative 
control (Figure 2.4, Lane 13) showed only low weight molecular bands. The DNA extraction 
positive control (Figure 2.4, Lane 12) showed an amplicon of the expected size (~320 bp). 
Amplicons of the expected size were present for all but one of the oral samples (P3-Saliva, Figure 
4, Lane 9). DNA quantification revealed majority of samples to have detectable concentrations of 
dsDNA (Table 2.3). This was confirmed by PCR amplification and gel electrophoresis revealing 
majority of the samples to have visible amplicon products around the expected size of 320 base 
pairs (Figure 2.4). DNA concentrations were calculated using fluorescence correlated with the 
intensity of the bands observed in gel electrophoresis. DNA extraction negative and positive 
controls demonstrated that there was no bacterial contamination during the DNA extraction and 
PCR steps. Additionally the protocol was confirmed to be effective in extracting V4 16S DNA from 
stored vaginal samples. Boiling oral samples and the removal of salivary supernatant directly after 
sample collection resulted in observable ~320bp bands amplified from DNA extracted from these 
samples. Faint amplicon bands (~320bp) were visible for samples where quantification using 
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fluorescence was not able to detect dsDNA, indicating  V4 16S DNA amplification is possible from 
samples with very low DNA yields.   
 
Table 2.3: Concentration of dSDNA extracted from fresh oral and stored vaginal samples   
    Extracted DNA conc (ng/ μl) 
Sample ID Pre-
extraction 
processing 
Sample type DNA Extraction 
kit 
Periodontal Saliva LWM 
P1 Boiled Fresh Powersoil 0.104 0.066 - 
P2 Boiled Fresh Powersoil > 0.05 > 0.05 - 
P3 Boiled Fresh Powersoil > 0.05 > 0.05 - 
P4 Boiled Fresh Powersoil 0.404 > 0.05 - 
P5 Boiled Fresh Powersoil 0.214 0.142 - 
P6  None Fresh Powersoil - - 0.812 
 
 
Figure 2.4: Gel electrophoresis visualisation of PCR products of amplified 16S rRNA gene V4 product from fresh 
oral samples using the PowersoilTM DNA Isolation Kit (MoBio). Gel electrophoresis was carried out as described in 
2.1.4. O’Gene Ruler 100bp Plus DNA Ladder (Thermo Scientific) was included at 0.5 μg/ml in the left most lane for 
DNA band size estimation. Lanes 2-6 contain amplicon products after PCR amplification of extracted periodontal 
samples. Lanes 7-11 contain amplicon products after PCR amplification of extracted periodontal samples. Lane 12 
and 13 contain positive and negative DNA extraction controls respectively. 
 
 
3.3.2.3 Optimization Experiment 3: DNA Extraction from stored oral samples with boiling 
prior to extraction 
 
As a number of the samples had already been collected and stored at -80 OC, we next investigated 
post-thawing processing of stored oral samples prior to DNA extraction using DNA extraction 
protocol optimised for stored vaginal lateral wall samples. For this, periodontal and saliva 
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samples were removed from -80OC storage and thawed on ice. Prior to extraction, thawed 
samples were processed (by boiling and the removal of salivary supernatant) as described in 
2.2.2. DNA  was quantified using the Quant-iTTM High-Sensitivity DNA Assay Kit (Invitrogen) and 
Qubit 2.0 Fluorometer (Invitrogen) as described in 2.1.3. Extracted DNA was then amplified using 
PCR and gel electrophoresis was performed as described in 2.1.4. DNA quantification revealed 
33% of the extracted oral samples to have DNA concentration lower than the detectable range 
(Table 2.4). Amplicons of the expected size were present for the majority of samples  (Figure 2.5). 
Boiling oral samples and the removal of salivary supernatant directly after thawing samples from 
storage at -80OC resulted in observable ~320bp bands amplified from DNA extracted from these 
samples. This additional sample processing allowed for sufficient DNA extraction and 
amplification using the PowersoilTM DNA Isolation Kit (MoBio) and procedures described in 2.1 
 
 
Table 2.4: Concentration of dsDNA extracted from stored oral samples   
    Extracted DNA conc (ng/ μl) 
Sample ID Pre-extraction 
processing 
Sample 
type 
DNA Extraction 
kit 
Periodontal Saliva 
UC-013 Boiled after thawing Stored  Powersoil 0.981 0.043 
UC-015 Boiled after thawing Stored Powersoil 0.760 1.23 
UC-016 Boiled after thawing Stored  Powersoil 0.690 0.142 
UC-017 Boiled after thawing Stored Powersoil > 0.05 0.997 
UC-018 Boiled after thawing Stored  Powersoil > 0.05 > 0.05 
UC-021 Boiled after thawing Stored  Powersoil > 0.05 1.02 
UC-022 Boiled after thawing Stored Powersoil 0.234 0.098 
UC-024 Boiled after thawing Stored  Powersoil 0.187 0.654 
UC-028 Boiled after thawing Stored Powersoil 0.344 0.056 
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Figure 2.5: Gel electrophoresis visualisation of amplified 16S V4 DNA extracted from stored oral samples using the 
PowersoilTM DNA Isolation Kit (MoBio). Gel electrophoresis was carried out as described in 2.1.4. Lanes 2,3 and 5-
12 contain amplicon products after PCR amplification of extracted saliva samples. Lanes 13-23 contain amplicon 
products after PCR amplification of extracted periodontal samples. Lane 1 and 4 contain O’Gene Ruler 100bp Plus 
DNA Ladder (Thermo Scientific) included at 0.5 μg/ml.  
 
3.3.2.4 Optimization Experiment 4: DNA Extraction from stored samples with boiling prior to 
storage 
 
We additionally investigated pre-storage processing of stored oral samples prior to DNA 
extraction using the DNA extraction protocol optimised for stored vaginal lateral wall sample. 
Upon receipt in the lab, periodontal samples were vortexed and were boiled at 95OC for 10 
minutes prior to storage at -80OC. Salivette samples were centrifuged at room temperature for 5 
minutes at 4000 rpm. The swab was discarded and the filtrate was transferred into a 2mL cryovial 
and boiled at 95OC for 10 minutes before a 15 minute centrifugation at 4000g (RCF) at 4°C. 
Leaving 100μl, supernatant was removed at stored at -800C. The pellet was resuspended in the 
remaining 100μl of supernatant and 300μl Tris (pH 8.0)  buffer prior to storage at -80OC. After a 
minimum of 2 weeks storage at -80 OC, periodontal and saliva samples were thawed on ice and 
DNA was then extracted following the protocol described in 2.1 using the PowersoilTM DNA 
Isolation Kit (MoBio). DNA  was quantified using the Quant-iTTM High-Sensitivity DNA Assay Kit 
(Invitrogen) and Qubit 2.0 Fluorometer (Invitrogen) as described in 2.1.3. Extracted DNA was then 
amplified using PCR and gel electrophoresis was performed as described in 2.1.4. DNA 
quantification revealed 65% of the extracted oral samples to have DNA concentration lower than 
the detectable range (Table 2.5). The DNA extraction negative control (Figure 2.6, Lane 14) 
16 17 18 21 22 23 28
PeriodontalSaliva
24 16 17 18 21 22 23 28241513 291513
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showed only low weight molecular bands and no detectable DNA was identified through 
fluorescence. Amplicons of the expected size  (~320bp) were present for the majority of samples  
(Figure 2.6).  Gel electrophoresis resulted distinctly higher yield amplicon products for 
periodontal samples in comparison to saliva samples (Figure 2.6). Pre-storage processing, 
including boiling oral samples and the removal of salivary supernatant prior to DNA extraction 
allowed for sufficient DNA extraction and amplification using the PowersoilTM DNA Isolation Kit 
(MoBio) and procedures described in 2.1. DNA amplicon yields from periodontal samples are 
distinctly higher than those from saliva samples, most likely due to salivary PCR inhibitors.  
 
Table 2.5: Concentration of dsDNA extracted from stored oral samples   
    Extracted DNA conc (ng/ μl) 
Sample ID Pre-extraction 
processing 
Sample 
type 
DNA Extraction 
kit 
Periodontal Saliva 
UC-062 Boiled after thawing Stored  Powersoil <0.05 <0.05 
UC-072 Boiled after thawing Stored Powersoil 0.462 1.52 
UC-073 Boiled after thawing Stored  Powersoil <0.05 <0.05 
UC-084 Boiled after thawing Stored Powersoil 0.269 <0.05 
UC-089 Boiled after thawing Stored  Powersoil <0.05 <0.05 
UC-090 Boiled after thawing Stored Powersoil 0.069 <0.05 
UC-091 Boiled after thawing Stored  Powersoil 0.069 <0.05 
 
 
 
Figure 2.6: Gel electrophoresis visualisation of amplified 16S V4 DNA extracted from stored oral samples using the 
PowersoilTM DNA Isolation Kit (MoBio). Gel electrophoresis was carried out as described in 2.1.4. O’Gene Ruler 
100bp Plus DNA Ladder (Thermo Scientific) was included at 0.5 μg/mL in the left most lane for DNA band size 
estimation. Lanes 2-8 contain amplicon products after PCR amplification of extracted periodontal samples. Lanes 8-
15 contain amplicon products after PCR amplification of extracted periodontal samples. Lane 16 contains the 
negative DNA extraction control. 
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3.3.2.5 Optimization Experiment 5: Comparison  of two commercially available DNA 
extraction kits to extract 16S DNA from oral, vaginal and foreskin samples 
While the PowersoilTM DNA Isolation Kit (MoBio) was shown to be sufficient for extracting 16S 
DNA from both oral and vaginal samples, we identified a second commercially available kit, the 
Quick-DNA™ Fungal/Bacterial Kit (Zymo Technologies),  with a significantly shorter protocol time 
(~3 hours as opposed to the ~5 hours), and previously shown to be superior in DNA extraction 
for similar purposes (Claassen et al. 2013). This experiment aimed to compare performance of 
both kits in extracting bacterial DNA for the purpose of the previously described protocol. Stored 
saliva, lateral vaginal wall and foreskin swab samples were thawed on ice. Prior to storage, lateral 
vaginal wall and saliva samples had been processed and stored as described in 1.2.1. Foreskin 
swabs from a previous study (HREC ref: 566/2012) were included as additional low biomass 
samples. These were collected by swabbing the inner foreskin with a flocked swab (MDG 
diagnostics) and stored at -80 O C.   All samples were split into duplicate aliquots and enzyme 
digestion was followed as described in 2.1. DNA was extracted from one set of duplicates using 
the PowersoilTM DNA Isolation Kit (MoBio) as described in 2.2.1.  DNA was extracted from the 
other set of duplicates using the Quick-DNA™ Fungal/Bacterial Kit (Zymo Technologies) and the 
manufacturer’s instructions were followed with slight modifications as follows: All 
centrifugations were carried out in a microcentrifuge. Briefly, 500μl of sample and 250μl of 
Bashing BeadTM Buffer was added to ZR Bashing BeadTM Lysis Tubes. Tubes were homogenised 
using TissueLyser LT (Qiagen) for 5 minutes at 50Hz. ZR Bashing BeadTM Lysis Tubes were then 
centrifuged at 10 000g for 1 minute. Up to 400μl supernatant was transferred  to the Zymo-SpinTM 
III-F Filter in a Collection Tube and centrifuge at 8 000 g for 1 minute. The Zymo-SpinTM III-F Filter 
was the discarded and 1200μl of Genomic Lysis Buffer (with beta-mercaptoethanol added to a 
final dilution of 0.5%(v/v)) was added to the filtrate in the Collection Tube from the previous step. 
Up to 800μl of this mixture was transferred to Zymo-SpinTM IC Column in a Collection Tube and 
centrifuged at 10 000 g for 1 minute. The filtrate was discarded and this step was repeated before 
the Zymo-SpinTM IC Column was transferred to a new collection tube and 200μl of DNA Pre-Wash 
Buffer was added to the column. The column was centrifuged for at 10 000 g for 1 minute and 
the filtrate discarded. This step was then repeated using 500μl of g-DNA Wash Buffer. The Zymo-
SpinTM IC Column was transferred to a clean 1 ml microcentrifuge tube and 50μl DNA Elution 
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Buffer was added directly to the column matrix and incubated for 1 minute. The tube was 
centrifuged at 10 000 g for 30 seconds to elute the DNA. This step was repeated using another 
50μl DNA Elution Buffer resulting in eluted DNA in a final volume of 100μl. Extracted DNA was 
stored at -20OC for downstream processing. DNA  was quantified using the Quant-iTTM High-
Sensitivity DNA Assay Kit (Invitrogen) and Qubit 2.0 Fluorometer (Invitrogen) as described in 
3.3.1.4 . Extracted DNA was then amplified using PCR and gel electrophoresis was performed as 
described in 3.3.1.5. 
  
When comparing these two kits, DNA quantification of samples extracted using the Zymo kit 
revealed all samples to have detectable dsDNA concentrations (>0.05 ng/ml)  (Table 2.6). Of the 
samples extracted using the Mobio kit, dsDNA was not detected in 33% of samples  (Table 2.6). 
The DNA extraction negative control for both kits (Figure 2.7, Lanes 19 and 20) showed only low 
weight molecular bands and no detectable DNA was identified through fluorescence (Table 2.6). 
Amplicons of the expected size (~320bp) were present for all saliva samples (Figure 2.7, Lanes 1-
6). For all saliva samples, the Zymo kit produced a brighter amplicon band in comparison to 
extraction done with the Mobio kit. Amplicons were present for 2 out of the 3 foreskin samples 
(Figure 2.7, Lanes 7-12) with no distinct difference in the brightness of amplicons bands between 
samples extracted using the difference kits observed. Amplicons of the expected size were 
present for all vaginal samples extracted from both kits, with slightly brighter bands observed for 
the Zymo extractions (Figure 2.7, Lanes 13-18).  Gel electrophoresis resulted distinctly higher 
yield amplicon products for vaginal samples in comparison to saliva samples (Figure 2.7). DNA 
concentrations calculated using fluorescence did not correlate with the intensity of the bands 
observed in gel electrophoresis. In this experiment, dsDNA quantification did not give a reliable 
indication of the performance of the two extraction kits compared as high yield amplicon ~320 
bp were observed for vaginal samples where dsDNA was recorded as below the detectable range. 
This may be a result of the light reactivity of the reagents used in the DNA quantification protocol 
resulting in inaccurate DNA readings. Based on the gel electrophoresis result and the 
corresponding DNA quantification using both Qubit and Nanodrop, for the majority of samples, 
the use of the Zymo kit resulted in higher yields of amplicons after V4 16S PCR amplification. Due 
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to this and the shorter protocol time required for the Zymo kit extractions, the Zymo kit was used 
for all further DNA extraction in this study.  
 
Table 2.6: Concentration of dsDNA extracted from fresh oral and stored vaginal samples   
  Extracted DNA conc (ng/ μl) 
  Qubit Nanodrop  
Sample  Type Zymo kit MoBio kit Zymo kit MoBio kit 
Saliva 1 Fresh 0.234 <0.05 8.9 1.6 
Saliva 2 Fresh 0.145 0.263 11.1 1.3 
Saliva 3 Fresh 0.131 0.098 13.1 0.9 
Foreskin 1 Stored 2.93 3.44 11.2 4.9 
Foreskin 2 Stored  1.05 0.761 16.4 3.4 
Foreskin 3 Stored 0.731 0.748 17.5 3.8 
Vaginal 1 Stored  0.190 <0.05 11.4 1.8 
Vaginal 2 Stored 1.49 0.205 12.7 3.5 
Vaginal 3 Stored 0.064 <0.05 14.3 2.3 
Neg Control - <0.05 <0.05 4.0 1.2 
 
 
Figure 2.7: Gel electrophoresis visualisation of amplified 16S V4 DNA extracted from stored oral samples using the 
PowersoilTM DNA Isolation Kit (MoBio). Gel electrophoresis was carried out as described in 2.1.4. O’Gene Ruler 
100bp Plus DNA Ladder (Thermo Scientific) was included at 0.5 μg/ml in the right most lane for DNA band size 
estimation. Lanes 1-6 contain amplicon products after PCR amplification of extracted saliva samples. The gel contains 
amplicon products after PCR amplification for saliva (S, lanes 1-6), foreskin (F, lanes 7-12) and vaginal (V, lanes 13-
18) extracted using the Mobio (M) and Zymo (Z) kits. Lanes 19,20 and 21 contain negative controls for the Mobio 
extraction, Zymo extraction and PCR.   
 
 
 
 
 51 
 
 
3.3.3 Summary of findings  and resultant protocol changes from 16S rRNA gene V4 DNA 
extraction optimization 
The protocol described for enzyme digestion for the extraction of 16S microbial DNA (3.3.1.2), 
16S DNA Quantification (3.3.1.4) and gel electrophoresis (3.3.1.5) remained unchanged. Based 
on the previously described optimisation experiments the following changes were made to the 
samples processing and DNA extraction protocols: 
- Boiling and the removal of salivary supernatant from oral samples either prior or post -80OC 
storage increases the yield of bacterial DNA extracted from oral samples. This additional 
processing was included prior to -80O C storage for all periodontal and saliva samples. For all 
samples already in -80O C storage, this additional processing was included after samples were 
thawed prior to DNA extraction.   
- The yield of DNA extracted from periodontal and saliva samples is lower than that of DNA 
extracted from lateral vaginal wall samples. Based on this, for the purpose of DNA library 
preparation for MiSeq sequencing, oral sample V4 16S rRNA gene amplification was planned to 
be performed in duplicate and pooled prior to subsequent protocol steps. 
- V4 16S rRNA gene PCR amplification is possible from samples where quantification using 
fluorescence was not able to detect dsDNA. Based on this, the maximum volume (10uL) of all 
low yield samples (periodontal and saliva) were included during the V4 16S amplification step 
of DNA library preparation for MiSeq sequencing.  
- In comparison to the MoBio, the Zymo kit resulted in improved amplification of V4 16S rRNA 
gene product. Due to this and the shorter protocol time required for the Zymo kit extractions, 
the Zymo kit was used for all further DNA extraction in this study. 
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3.4 Illumina 16S rRNA iTag library preparation 
3.4.1 Previously validated Illumina 16S rRNA iTag library preparation protocol 
 
As with the DNA extraction,  a previously validated protocol developed for Illumina 16S rRNA iTag 
library preparation from V4 16S rRNA gene DNA extracted from vaginal lateral wall swabs was 
originally used to prepare DNA libraries containing matched oral and vaginal samples from this 
study (Lennard et al. 2018). DNA libraries were prepared in 96-well plates including 92-samples 
and 4 controls: PCR 1 negative control, PCR 2 negative control, extraction negative control and 
positive PCR  control (detailed description to follow). Where possible, participant matched 
samples (lateral wall, periodontal and saliva) were included in the same library. Library 
preparation included the followings steps: An initial round of PCR to amplify the V4 hypervariable 
region of the 16S bacterial chromosome from extracted dsDNA,  bead purification of amplicons 
from the first round of PCR, a second round of PCR to attach Illumina adaptors and sequencing 
barcodes, bead purification of amplicons from the second round of PCR, library pooling and gel 
purification of final pooled library.  
 
3.4.1.1 PCR 1: Amplification of the V4 16S hypervariable region  
The V4 hypervariable region of the bacterial 16S rRNA gene was amplified by PCR using the 
protocol described in 3.3.1.5. The following negative controls with the following substitutions for 
clinical samples were included:  a negative PCR control with 10μl of DNase free H2O and a 
negative extraction control with 10μl of an extraction control from a DNA extraction matching 
samples included in the library. For the purpose of a positive control for both the extraction 
efficiency, amplification and data processing pipeline, DNA was extracted from a microbial mock 
community of known composition (ATCC, HM-280) according to the protocol described in 3.3.1.3. 
HM-280 mock community C is an microbial cell mixture of even amounts of 22 different bacterial 
strains in phosphate buffered saline (PBS) and full details of the community composition can be 
found in the Appendix. Amplification of DNA from oral samples (periodontal and saliva) were 
performed in duplicate and pooled in the subsequent bead purification step. Amplicons were 
quantified using the Quant-iTTM High-Sensitivity DNA Assay Kit (Invitrogen) and Qubit 2.0 
Fluorometer (Invitrogen) as described in 3.3.1.4.  PCR amplicon plates were sealed and stored at 
-20OC for up to a week.  
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3.4.1.2 PCR 1 purification: Bead purification and visualization 
The Agencourt AMPure XP PCR purification system (Beckman Coulter) were used to purify 
amplicons from the first round of PCR in order to removing excess primers, nucleotides, salts, 
and enzymes that may inhibit downstream amplification and sequencing processes. The 
manufacturer instructions were followed with the following changes: PCR products were thawed 
on ice and an aliquot of AMPure XP beads was brought to room temperature. PCR plates were 
centrifuged to collect condensation and the seals were carefully removed. Duplicate oral samples 
were pooled resulting in a single plate containing vaginal samples (25μl of amplicon) and pooled 
oral samples (50μl of amplicon). AMPure XP beads were vortexed until beads were evenly 
dispersed and an equivalent amount of beads was added to each amplicon sample (25μl for 
vaginal samples and 50μl for oral samples). Beads were mixed well by pipetting and incubated at 
room temperature for 10 minutes.  The plate was then placed on the Magnetic Stand-96 
(Invitrogen) for 2 minutes or until supernatant had cleared. The supernatant was discarded and 
200μl of freshly prepared 80% ethanol was added to each sample well. The plate was incubated 
on the magnetic stand for 30 seconds before the supernatant was removed an discarded. This 
ethanol wash step was repeated before beads were air dried for 2 minutes. The plate was 
removed from the magnetic stand and 27.5μl of 10 mM Tris pH 8.5 was added to each well and 
mixed by pipetting until beads were fully resuspended.  The plate was incubated at room 
temperature for 2 minutes before being placed on the magnetic stand. After 2 minutes or once 
the supernatant had cleared, 25μl of the supernatant was carefully transferred into a new PCR 
plate. Purified amplicons were stored at -20 O C for up to a week.  
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Figure 2.8: Workflow for PCR amplicon purification using the Agencourt AMPure XP PCR purification system. 
Edited from: Instructions for use: Agencourt AMPure XP PCR Purification, Beckman Coulter. Accessed online at: 
https://genome.med.harvard.edu/documents/sequencing/Agencourt_AMPure_Protocol.pdf 
 
After bead purification, purified amplicons were quantified and visualised with gel 
electrophoresis as described in 3.3.1.4 and 3.3.1.5. Successful amplification was determined by 
the presence of a clear band (~320bp). For samples where no band was present, the first round 
of PCR and bead purification was repeated once using the maximum sample volume for the PCR 
reaction (10 μl). If no amplification was evident after repeated amplification and bead 
purification was, samples were excluded from the library. Purified amplicon plates were sealed 
and stored at -20 O C for up to a week.  
 
3.4.1.3 PCR 2: Limited cycle multiplexing PCR  
A second round of PCR was run in order to attach dual indices and Illumina sequencing adapters 
to the amplified V4 hypervariable region of the bacterial 16S rRNA gene using the Nextera XT 
Index Kit (llumina). Eight forward primers and twelve reverse primers were used in unique 
combinations to distinguish samples for MiSeq multiplexing. These primers were added to the 
amplicon products by a short cycle PCR described in Tables 2.7 and 2.8. A master mix was created 
containing:  5μL (2.5μM/μl) each of the unique forward and reverse primers (full combination 
supplied in appendix) and 25μl high fidelity DNA polymerase KAPA Hotstart Mix (Thermo 
Scientific™ Phusion™). Variable amounts of template amplicon from the initial round of PCR were 
added (max volume 5μl), to reach a 15-20ng of template amplicon in each reaction. Variable 
amounts of DNase free H2O was then added to reach a final reaction volume of 50μL per sample 
(Table 2.7). PCR reactions were run using the GeneAmp® PCR System 9700 according to the 
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following program: 1 cycle 95°C for 3 minutes, 8 cycles of 95°C for 30 seconds, 55°C for 30 seconds 
and 72°C for 30 seconds, 1 cycle of 72°C for 5 minutes hold at 4°C (Table 2.8). A PCR 2 negative 
control was included  where 5μl of DNase free H2O was substituted for template amplicon in the 
above described mastermix.  
 
Table 2.7: Reagent list for PCR 2  Table 2.8: Thermocycler protocol for PCR 2 
Reagent Amount to add  PCR phase Duration/temperature 
Template DNA Max 5μl (to ~15-20ng DNA)  Initial denaturation 95°C for 3 minutes 
Forward primer 5μl  Cycles (x8)  
Reverse primer 5μl      Denaturation 95°C for 30 seconds 
KAPA Hotstart Mix 20μl      Annealing 55°C for 30 seconds 
PCR H2O 10μl (up to final volume of 25μl)      Elongation 72°C for 30 seconds 
Total volume: 50μl  Final Elongation 72°C for 30 seconds 
   Storage 4°C 
 
 
 
3.4.1.4 PCR 2: Bead purification 
Amplicons from PCR 2 were purified using Agencourt AMPure XP beads (Beckman Coulter) as 
described in 3.4.1.2.  After bead purification, purified amplicons were quantified and visualised 
with gel electrophoresis as described in 3.3.1.4 and 3.3.1.5. Successful amplification was 
determined by the presence of a clear band (~450bp). For samples where no band was present, 
the second PCR and bead purification was repeated once using the maximum samples volume 
(5μl). If no amplification was evident after the second PCR and purification were repeated, 
samples were excluded from the library. Purified amplicon plates were sealed and stored at -20 
O C for up to a week.  
 
3.4.1.5 Library normalizing and pooling 
Amplicons were pooled in equimolar amounts. This was achieved by identifying the sample with 
the lowest amplicon concentration in the library and adding all remaining samples to the pooled 
aliquot at the same concentration. The concentration of the final pooled library was quantified 
using the Quant-iTTM High-Sensitivity DNA Assay Kit (Invitrogen) and Qubit 2.0 Fluorometer 
(Invitrogen) as described in 2.1.4 and stored at 4OC.  
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3.4.1.6 Pooled library purification (gel extraction) 
The QIAquick PCR Purification Kit (Qiagen) was used to purify the final pooled library, in order to 
remove non-specific amplification and primer-dimers. Gel purification was run according to the 
manufacturers recommendations. Briefly, all centrifugations were carried out in a 
microcentrifuge at 13 000g. Buffer PB was added to the final pooled library at a 5:1 ratio. This 
mixture was added to a QIAquick column placed in a collection tube and centrifuged for one 
minute.  The flow-through was discarded and the column was washed with 750μl before a one 
minute centrifugation. The QIAquick column was placed in  a clean 1.5 ml microcentrifuge tube 
and DNA was eluted using  30μl Buffer EB (10 mM Tris·Cl, pH 8.5) and a one minute 
centrifugation.  Loading dye was added to the flow through at a 5:1 ratio and mixed by pipetting. 
The DNA library was run on a 1% agarose gel (Tris–Acetate–EDTA (TAE) buffer, 60 V,  60 min). 
DNA was visualised using a handheld UV light and excised from the gel with a disposable scalpel. 
Gel fragments were weighed and placed in a collection tube with Buffer QG added at a 3:1 ratio 
(100mg ~100μl). The gel fragments were incubated at 50O C for 10 minutes or until the gel had 
completely dissolved. Isopropanol was added to the mixture at a ratio of 1:1 and mixed by 
pipetting. The sample was transferred to a QIAquick column in a collection tube and centrifuged 
for one minute. The flow through was discarded and the filter was washed using 500μl of Buffer 
QG and a one minute centrifugation. The flow through was again discarded and second wash was 
done as in the previous step using 750μl of Buffer PE after a 5 minute incubation at room 
temperature. The column was then dry centrifuged for one minute. After transferring the column 
into a clean collection tube, DNA was eluted in 30μl of elution buffer (10 mM Tris·Cl, pH 8.5) with 
a one minute centrifugation. The concentration of the purified library was determined using the 
Qubit 2.0 Fluorometer (Invitrogen) and the Quant-iTTM High-Sensitivity DNA Assay Kit 
(Invitrogen) according to the manufacturers protocol.  Purified DNA libraries were stored at 4OC.  
 
3.4.2 Optimisation of Illumina 16S rRNA gene MiSeq library preparation protocol 
3.4.2.1 Initial library quality assessment 
The Bioanalyzser 2100 (Agilent) was used to assess the quality of amplicons in the pooled library. 
Protocols were followed according to manufactures specifications. Briefly, the RNA 6000 Nano 
Assay (Agilent Technologies Inc., part No. G2941-90126) was used to prepare an RNA 6000 Nano 
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gel matrix according to manufacturer’s specifications. Libraries were denatured at 70OC for 2 
minutes and then centrifuged quickly before being placed on ice. Gel dye mix, RNA 6000 Nano 
Markers (15bp and 1500bp) and Ladder were added to the chip according to manufacturer’s 
specifications. Libraries were added to the chip in 1μl aliquots and the chip was vortexed at 2400 
rpm. The chip was loaded into the Bioanalyzer 2100 within 5 minutes of preparation and software 
analysis protocols were run according to manufacturer’s specifications. Bioanalyzer results from 
the first library prepared revealed a peak correlating to an amplification product ~410bp, in 
addition to a peak correlating to the expected amplicon product (~450 bp) (Figure 2.9). This was 
an indication of non-specific amplification and the Section 3.3.2 describes the optimisation that 
took place to correct for this.  
 
 
Figure 2.9: Size of denatured RNA fragments (bp) in initial DNA library measured by fluorescence [FU] using the 
Bioanalyzser 2100 (Agilent).  
 
 
 
 
 
Marker #1 
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3.4.2.2 Optimisation Experiment 7: Optimisation of Limited cycle multiplexing PCR 
In order to reduce non-specific product formation during the second round of PCR in the 16S 
rRNA MiSeq library preparation protocol, we assessed the impact following changes to the 
protocol described in 3.4.1: 
- Increasing the primer concentration from 0.1 to 0.5μM   
- Increasing cycle numbers from 8 to 15 
- Varied concentration of template amplicon from the first round of PCR amplification 
The reverse primers tested were chosen based on quality control results for previous libraries in 
which samples with primers S501 and S504 gave poor results. The forward primers were 
randomly chosen. The second round of PCR was run as described in 3.1.3 with the following 
alterations: 18 separate PCR reactions with different combinations of primer concentrations, 
cycle numbers and starting sample concentration according to Table 2.9.  
 
Table 2.9: Reagent list for PCR 2 optimisation 
Combination: 1 2 3 4 Control 
Primer conc (uM) 0.1 0.5 0.1 0.5 0.1 
No. of cycles 15 15 8 8 15 
Amplicon conc (ng/ul) 13.7 13.7 6.9 6.9 - 
Mastermix      
Template DNA (μl)* 10 10 5 5 - 
Forward primer (μl) 5 5 5 5 5 
Reverse primer (μl) 5 5 5 5 5 
KAPA Hotstart Mix (μl) 20 20 20 20 20 
PCR H2O - - - - 10 
 
Gel electrophoresis revealed that increasing the primer concentration from 0.1 μM  to 0.5μM  
showed slight improvement in amplification specificity with fewer non-specific low molecular 
weight amplifications present in the reactions with higher primer concentrations (Figure 2.10). 
Increasing the number of PCR cycles from 8 to 15 resulted in a number of additional amplification 
products above the expected product size of 460 bp (Figure 2.10). Reducing the initial 
concentration of amplicons from the first PCR (template DNA for the 2nd PCR) also resulted in 
fewer non-specific amplifications (Figure 2.10).   
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Figure 2.10: : Gel electrophoresis visualisation of PCR optimisation. Gel electrophoresis was carried out as 
described in 2.1.4. O’Gene Ruler 100bp Plus DNA Ladder (Thermo Scientific) was included at 0.5 μg/mL in the left 
most lane for DNA band size estimation.  
 
Based on the results of the above optimisation experiment, the 2nd PCR was run using 8 
elongation cycles. Amplicon products from the 1st PCR were diluted to  ~3.0-6.0 ng/ul before the 
2nd PCR and the final primer concentration was increased to 0.2uM.  
 
3.5 MiSeq Sequencing 
The concentration of the pooled library was determined using the Qubit 2.0 Fluorometer 
(Invitrogen) and the Kappa library quantification kit (Roche) according to the manufacturers 
protocol. DNA libraries were diluted to a concentration of 4.0 nM using nuclease free H2O. Diluted 
libraries were then denatured by adding 0.2N sodium hydroxide (NaOH) and a 5 minute 
incubation at room temperature. Denatured libraries were diluted to concentration of 1.3nM by 
adding 200nM Tris-HCl (pH 7) before an additional dilution to a concentration of 20pM with pre-
chilled hybridization buffer. Finally, samples were heat denatured for 2 minutes at 96°C before 
MiSeq sequencing. For each run, a 20% % PhiX internal control spike-in was included at the same 
concentration of the DNA library. All reagents used were from the MiSeq Reagent Kits V3 
(Illumina). Amplicon sequencing was performed on the Illumina MiSeq Desktop Sequencer (300-
bp paired-end reads with V3 chemistry) .  
100 bp     1         2         3         4         5         6         7         8         9        10       11      12      13 14       15       16       17      18       
100 bp 1U        1D         3          4           7          8          11        12         15        16      
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
701 701 701 701 702 702 702 702 701 701 701 701 702 702 702 702 701 702
501 501 501 501 501 501 501 501 504 504 504 504 504 504 504 504 501 504
0.1 0.5 0.1 0.5 0.1 0.5 0.1 0.5 0.1 0.5 0.1 0.5 0.1 0.5 0.1 0.5 0.1 0.1
15 15 8 8 15 15 8 8 15 15 8 8 15 15 8 8 15 15
13.7 13.7 13.7 13.7 6.9 6.9 6.9 6.9 13.7 13.7 13.7 13.7 6.9 6.9 6.9 6.9 H2O H2O
Reaction
Reverse primer
Forward primer
Primer conc (μM)
No. PCR Cycles
Amplicon conc (ng/μl)
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3.6 Bioinformatic pipeline 
De-multiplexed, raw reads were pre-processed using usearch7 and modules included in the 
QIIME package (Quantitative Insights Into Microbial Ecology, http://qiime.org). The quality of raw 
reads was assessed using FastQC (Andrews 2010). Using USEARCH, 250 bp paired-end reads were 
merged and then quality filtered (merged reads were truncated to 300bp and reads with error 
scores larger than 0.1 discarded). Next, sequences were de-replicated (the process of identifying 
and sorting replicate sequences) whilst recording the level of replication for each sequence. De-
replicated sequences were sorted by abundance (highest to lowest) and clustered de novo into 
operational taxonomic units (OTUs) at 97% similarity (Edgar 2018). Chimeric sequences were 
removed. Individual sequences were assigned to specific OTUs using a 97% similarity threshold. 
Taxonomic assignment was performed using the RDP classifier (against the Greengenes 13.8 
database) at a confidence level of 0.5 (Wang et al. 2007). The representative sequence set was 
then aligned against the Greengenes 13.8 database using PyNAST (Caporaso et al. 2010). As 
previous publications have described the vaginal microbiome of girls from the same study 
population in depth, manual taxonomic annotation was not performed for OTUs during vaginal 
microbiome analysis, except for cases where no annotation was available after taxonomic 
assignment using the Greengenes database. For oral OTU’s where species level annotation was 
not achieved using the previously described method, BLASTn searches were performed in the 
NCBI 16S ribosomal RNA sequence (bacteria and Archaea) database after excluding all uncultured 
bacteria. If more than one species mapped to an OTU, OTUs were annotated as follows: Genus 
species A_species B_species C for a maximum of three species. If more than three species mapped 
to an OUT or there was disagreement between the Greengenes and BLASTn annotation, the 
FASTA sequence was searched using BLASTn in the Human Oral Microbiome Database (eHOMD) 
and taxa previously identified from the human oral microbiome were selected. Finally, a 
phylogenetic tree was constructed using FastTree to relate OTUs from the multiple sequence 
alignment (Price et al. 2010). Based on rarefication analysis for optimal read count depth, 
samples with > 2000 reads were selected for downstream analyses.  
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3.7 Statistical analysis 
All downstream statistical analysis was performed in R. Beta diversity non-metric dimensional 
scaling (NMDS) was performed using Bray-Curtis and alpha diversity principal component(PC)  
analysis was performed using Weighted-Unifrac. Alpha diversity boxplots were generated using 
Shannon’s diversity and the Kruskal Wallis non-parametric variance test. Microbial community 
types were determined by fuzzy clustering with optimal k. For heat map and relative abundance 
plots, OTUs were merged at the lowest available taxonomic level using a custom script developed 
by Lennard et al.   (Lennard et al. 2017). OTU tables were then standardized (i.e., transformed to 
relative abundance and multiplied by the median sample read depth) and filtered so that each 
OTU had at least 10 counts in at least 10% of samples. Heatmaps were constructed using 
Weighted-Unifrac as a distance metric and  UPGMA unsupervised hierarchical clustering. 
Differential abundance testing was calculated using negative binomial models after filtering out 
OTUs where variance was lower than 30 and a predetermined level of significance (adjusted p-
value <0,05). Fold differences > 1.25 and < 0.75 were considered clinically significant. Ecological 
diversity was calculated using the phyloseq (Mcmurdie & Holmes 2013) package, cluster 
(Rousseeuw et al. 2018) was used for community type clustering, vegan (Oksanen et al. 2018) for 
ordinations and redundancy analysis, NMF (Gaujoux 2014) for annotated heat maps and DeSeq 
(Anders & Huber 2010) for differential abundance testing.  
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CHAPTER 4: Results 
4.1 Library quality assessment 
4.1.1 Rarefication and selection of samples based on read counts 
Bacterial DNA was extracted from lateral vaginal wall (LW), saliva (SAL) and periodontal (PE) 
samples of 94 participants (N total samples = 282, Figure 3.1). The V4 region of the 16S rRNA 
gene in these samples were sequenced in six separate libraries keeping matched LW, SAL and PE 
samples for each participant in the same library where possible. Reads from the six libraries were 
combined for downstream analysis. After QIIME quality filtering, four SAL and two PE samples 
were excluded (N samples after filtering = 276, Figure 3.1). Rarefaction curves demonstrated that 
the mean OTU depth plateaued at around 2000 read counts and based on this, all samples with 
read counts below 2000 were excluded. Of the eighteen samples excluded with less than 2000 
reads one originated from LW, 15 from SAL and two from PE samples (Figure 3.1). The final library 
used for downstream analysis contained 258 samples (93 LW, 75 SAL and 90 PE), 1 634 5216 
reads (with a median of 41066 reads per sample) and 1904 unique OTUs.  
 
4.1.2 Quality and compositional analysis of controls 
For each library, a mock bacterial community consisting of an even mixture of 22 known bacterial 
species was included to assess variability across sequencing runs (Appendix, Table S1). The 
heatmap in Figure 3.2 A illustrates the standardised read counts of the top 30 OTUs amplified 
from the mock communities in each MiSeq run. With the exception of one sample, Mock-run1 
where read counts were low overall, bacterial species known to be present in the mock 
community (Table 3.1) were present at much higher read counts in each sample in comparison 
to unexpected bacterial species (Figure 3.2A). Of the 22 bacterial species present in the mock 
community, only Propionibacterium acnes was not identified in any of the samples. Twelve OTUs 
were identified at the species level after searching representative sequences using BLASTn 
against the NCBI 16S ribosomal RNA (bacteria and Archaea) (Edgar 2018) database with identity 
scores >97%, including Acinetobacter baumannii, Pseudomonas aeruginosa, Bifidobacterium 
adolescentis, Streptococcus mutans, Streptococcus agalactiae, Helicobacter pylori, Bacillus 
cereus, Rhodobacter sphaeroides, Porphyromonas gingivalis, Escherichia coli,  
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Figure 3.1: Schematic of sample selection after sequencing quality assessment and rarefication curves illustrating 
species richness (number of OTUs) with increasing number of reads per sample for (A) all samples and (B) and (C) 
vaginal and oral samples, respectively. Rarefaction was performed using the vegan (Oksanen et al. 2018) package in 
R.  
Deinococcus radiodurans and Bacteroides vulgatus. Species level annotation was not available 
for the OTUs mapping to Enterococcus. Two OTUs mapped to the Neisseria genus, with one 
identifiable at N. cinerea and species level resolution not possible for the other. There was only 
one OTU of Staphylococcus despite two Staphylococcus species being present in the mock 
community. We were thus unable to distinguish between Staphylococcus aureus and S. epidermis 
and this OTU was therefore annotated as S. aureus_epidermis_cluster for the purpose of this 
study. Additionally, as observed in other studies (Petricevic et al. 2012; Kiss et al. 2007; Vasquez 
et al. 2002), a single OTU mapped to both  Lactobacillus gasseri and L. jonsonnii. Due to the fact 
that L. gasseri was known to be present in the mock community this OTU is referred to as L. 
gasseri for the purpose of this study. The same logic was applied in downstream analysis where 
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some sequences mapped to more than one unique species and we used previous publications to 
determine the most likely identity. Putative sequences mapping to both Lactobacillus crispatus 
and L. acidophilus were referred to as L. crispatus due to previous literature noting the difficulty 
in differentiating these two species and identifying L. crispatus as a keystone vaginal species in 
the South African population (Lennard et al. 2018; Balle et al. 2018). Similarly the OTU identified 
as both A. odontolyticus and A. meyeri was annotated as A. odontolyticus, a keystone oral 
bacterium. The OTU mapping to the Clostridium genus was identified as C. butyricum. Due to the 
documented difficulty in distinguishing between C. butyricum and C. beijerinckii, the species 
known to be present in the mock community, this OTU was annotated as C. 
beijerinckii_butyricum_cluster. Listeria selegrii was identified instead of the expected L. 
monocytegens by both BLAST and Greengenes, likely the result of a sequencing error. In each 
sample, a number of bacteria known to be present at high proportions in the oral (Delftia 
acidovorans) and vaginal (Lactobacillus iners, Prevotella amnii, Megasphaera, BVAB-1, Sneathia 
sanguinegens and Gardnerella vaginalis) microbiotas respectively, were present at low read 
counts, possibly a result of spill over from oral and vaginal samples. In all samples, high read 
counts of Lysinibacillus were present. We were unable to determine the source from which this 
OTU originated, but may have been an environmental contaminant. As it was present across all 
mock community samples and was not picked up in downstream analysis or as one of the top 30 
OTUs in our analysis of negative controls (Figure 3.2 B), it likely the result of contamination 
specific to the mock communities introduced during handling of the mock community DNA. 
Similar to previous studies using the same even mock community (Fouhy et al. 2016), DNA 
extraction and MiSeq sequencing resulted in non-uniform amplification of different bacterial 
phyla with Enterrococus, N.cinerea, P. aeruginosa and E. coli overrepresented across all runs 
(Figure 3.2 A) despite a large variability in read count across mock communities (Appendix, Table 
S2). Negative controls, containing PCR grade nuclease free water in the place of genomic material 
were included for DNA extraction and/or PCR amplification in each MiSeq run. PCR controls for 
DNA extraction from sequencing run 1 were excluded in the QIIME quality filtering step, likely 
due to very low read counts. Although a range of bacteria were present in the negative controls 
(Figure 3.2B), the read counts for all controls (with the exception of PCR-2 Run 6) were well below 
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the 2000 read cut off point and there was no strong evidence of contamination.  
 
Figure 3.2: Composition and relative abundance of sequencing controls. Relative standardised read counts of the 
top 30 bacterial phyla and genera present in controls clustered by unweighted pair group method with arithmetic 
mean (UPGMA) hierarchical clustering using Weighted-Unifrac distances for (A) mock communities (N=6) and (B) 
negative controls (N=16). Colour scale indicates the relative read count of bacterial taxa present in each 
experimental control. (C) Relative abundance of bacterial taxa present in mock communities agglomerated at the 
lowest taxonomic level possible. The x-axis denotes sample type and the y-axis denotes % relative abundance of 
bacterial taxa contributing to the total makeup of the microbiota (100%). * Indicate species annotation with lower 
than 97% identity using BLASTn to search the eHOMD database.  
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4.1.3 Technical bias analysis 
Unsupervised hierarchical clustering of all samples illustrated that there was no clustering 
according to DNA extraction kit type (MoBio or Zymo) or MiSeq Run (Figure 3.3 A). In addition to 
this, NMDS analysis of all samples indicated that there were no distinct pattern in the beta 
diversity of samples introduced by either extraction kit type or MiSeq run (Figure 3.3 B). This 
analysis provides no evidence of technical bias introduced by DNA extraction or MiSeq 
sequencing and based on that, all samples were analysed together regardless of extraction kit or 
MiSeq run. 
Figure 3.3: Analysis for technical bias introduced by DNA extraction methods and MiSeq sequencing run. (A) 
Relative standardised read counts of the 30 top most abundant bacterial taxa in all samples (excluding controls, N 
= 258) clustered by UPGMA hierarchical clustering with colour scale indicating the relative read count (normalised 
by log2() for readability) of bacterial taxa in each sample. Samples were also analysed according to beta-diversity 
(B) using NMDS and Bray Curtis as a distance metric. The shape of the data points indicate the DNA extraction kit 
used and the colour indicates the MiSeq run in which samples were included. * Indicate species annotation with 
lower than 97% identity using BLASTn to search the eHOMD database.  
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4.2 Study cohort characteristics 
 
Table 3.1: Cohort baseline characteristics 
 Clinical BV Diagnosis 
 Negative (N=46) Positive (N=47) 
Mean Age (Std. Deviation) 17 (1,4) 17 (3,0) 
Mean BMI (Std. Deviation) 26 (4,6) 26 (5,4) 
Previous Pregnancy 11% (N=5) 15% (N=7) 
Any bacterial STI 48% (N=22) 53% (N=25) 
Chlamydia 35% (N=16) 36% (N=17) 
Gonorrhoea 11% (N=5) 21% (N=10) 
Trichomonas vaginalis 7% (N=3) 7% (N=3) 
HSV-2* 35% (N=16) 34% (N=16) 
Mycoplasma genitalium 4% (N=2) 4% (N=2) 
Vaginal samples included 46 47 
Saliva samples included 38 37 
Periodontal samples included 46 44 
 
After quality filtering as described previously, a total of 258 samples were included with at least 
one LW, SAL or PE samples originating from one of 93 participants. The mean age of participants 
in this cohort was 17 years with a higher distribution of ages in BV positive participants. Age, BMI, 
number of previous pregnancies and laboratory diagnosis of at least one bacterial STI were 
similar amongst BV positive and BV negative participants. In accordance with previous studies in 
this population (Balle et al. 2018; Lennard et al. 2017; Masson et al. 2015), the prevalence of 
bacteria STIs was relatively high compared to reports from the general population (Johnson & 
Geffen 2016). Chlamydia was the most prevalent STI in this cohort at 34%, followed by Herpes 
Simplex Virus 2 (HSV-2) at 34%, gonorrhoea at 15%, trichomonas at 6% and mycoplasma at 4%. 
While the prevalence of chlamydia, Trichomonas vaginalis, HSV-2 and Mycoplasma genitalium 
was similar in both experimental groups, the prevalence of gonorrhoea in girls with a clinical 
diagnosis of BV (21%) was double that of BV negative participants (10%). After quality filtering 
there were no large differences in the number of LW, SAL and PE samples included for each 
experimental group.  
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4.3 Composition of the oral microbiota 
4.3.1 Ecological niche and community type descriptions of the oral microbiota 
 
Fuzzy clustering of the oral samples with optimal k (described in method section) resulted in two 
distinctive oral community types (OCT 1 and OCT 2) that did not correlate to sampling site (Figure 
3.4 B) or by hierarchical clustering (Figure 3.5 A). The median alpha diversity measured by 
Shannon’s diversity Index was significantly (p<0.001) higher in OCT 1 [Median (variance) = 3.65 
(0.29)] compared to OCT 2 [Median (variance) = 2.78 (0.27)] (Figure 3.4 B). Both OCTs were 
dominated by Firmicutes with a relative abundance of 50% and 59% in OCT 1 and OCT 2, 
respectively. OCT 1 had a more diverse makeup at a genus level comprising of Streptococcus 
(15%), Prevotella (13%), Lactobacillus (9%), Selenomonas (5%), Staphylococcus (5%), 
Haemophilus (5%) and a number other genera with less than 5% abundance (Figure 3.5 B, Table 
3.2) compared to OCT 2 comprised predominately of Streptococcus (40%), followed by 
Haemophilus (10%), Neisseria (7%), Lautrophia (5%) and a number of low abundant genera 
(Figure 3.5 B, Table 3.2). S. dentisani_tigurinus_oralis was the most prevalent species in both 
OCTs, comprising 15.6% and 39% of the reads in OCT 1 and OCT 2, respectively (Figure 3.6 D, 
Table 3.2). Negative binomial modelling performed using Deseq2 (Paulson et al. 2013) identified 
a number of OTUs with significantly different relative abundances between OCTs, with only 
Streptococcus dentisani_tigurinus_oralis enriched in OCT 2 compared to OCT 1 with a clinically 
relevant fold difference of 0.25 (Appendix, Table S3). These results were supported by random 
forest modelling using all oral samples to predict OCT (Sensitivity (Sn) = 0.84, Specificity (Sp) = 
0.78, N= 165 with 85 and 80 samples per class), with S. dentasani_tigurinus_oralis identified as 
the most important bacteria distinguishing OCT 1 from OCT 2, followed by Granulicatella 
adiacens_balaenopterae, Gemella and Haemophilus. The full results of the random forest model 
are summarised in Figure 3.6 C and Appendix Table S5. Unsupervised hierarchical clustering of all 
oral samples (N=119) did not reveal any site specific differences in the relative abundance of the 
top 30 most prevalent OTUs between the salivary and periodontal microbiota (Figure 3.5 A). 
Negative binomial modelling identified significant differences in the less prevalent taxa between 
the SAL and PE samples as summarised in Figure 3.6 B and Appendix Table S4. Firmicutes, 
including Oribacterium spp. (O. parvum, O. asaccharolyticum and O. sinus) and Streptococcus 
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anginosus were enriched in the salivary microbiota, in addition to Prevotella nanceiensis and 
Actinobacteria including Actinomyces graevenitzii and Rothia mucilaginosa. The Fusobacterium, 
Leptotrichia (species level annotation not available) was present at a significantly higher 
proportion in the periodontal space. The results of a random forest model (Sn = 0.77, Sp = 0.92, 
N= 165 with 90 and 75 samples per class) identified R. mucilaginosa, O. sinus, S. 
thermophilus_vestibularis_salivarius, A. graevenitzii, P. nanceiensis and O. parvum as the most 
important species for accurately predicting the separation of the periodontal and salivary 
microbiota. The full results of the model and the most important classifying features are 
summarised in Figure 6D and Appendix Table S6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Ecological analysis of the oral microbiota (A) Comparison of alpha diversity (measured by Shannon’s 
Index) of oral samples by (A) sampling site (SAL = saliva and PE = periodontal) and (B) oral community types (OCT 1 
and OCT 2). Bars represent 95% confidence intervals. (C) NMDS analysis of beta diversity using Bray-Curtis as a 
distance metric of microbial communities in the mouth (saliva and periodontal samples, N = 165). The colours keys 
indicates the sampling site from which samples originated with yellow denoting saliva (SAL) and orange periodontal 
(PE) and the shape denotes the oral community type (OCT) derived from fuzzy clustering with an optimal k. *** 
denotes p <0,005.  
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Figure 3.5: Bacterial composition of oral microbiota (A) Relative standardised read counts of the 30 top most 
abundant bacterial taxa in oral samples (N=165)) clustered by UPGMA hierarchical clustering with colour scale 
indicating the relative read count of different bacterial taxa in each sample and colour key denoting the sample site 
(orange for saliva (SAL), yellow for periodontal (PE)) and oral community type (blue for OCT 1 and green for OCT 2). 
The composition of oral community types were also visualised with the relative abundance of bacterial taxa present 
in mock communities agglomerated at the on a (B) genus and (C) species level. The x-axis denotes sample type and 
the y-axis denotes % relative abundance of bacterial taxa contributing to the total makeup of the microbiota (100%). 
* Species annotation with lower than 97% identity using BLASTn to search the eHOMD database. 
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Table 3.2: Mean relative abundance of top 30 OTUs in oral community types** 
Phylum Genus Species Mean relative abundance 
   OCT 1 OCT 2 
Actinobacteria Actinomyces oris_naeslundii _viscosus* 2,3% 2,4% 
 Corynebacterium  3,5% 0% 
 Gardnerella vaginalis 2,0% 0% 
 Rothia mucilaginosa_cluster 0% 1,7% 
Bacteroidetes Capnocytophaga leadbetteri 0% 0,5% 
 Capnocytophaga   0% 0,5% 
 Porphyromonas pasteri 3,6% 1,3% 
 Prevotella  6,6% 0% 
 Prevotella melaninogenica 4,2% 2,0% 
 Prevotella intermedia 2,7% 0,7% 
 Prevotella  0% 1,6% 
Firmicutes Abiotrophia defective 0% 2,0% 
 Anaerococcus  1,6% 0% 
 Catonella morbi 0% 0,2% 
 Finegoldia  1,8% 0% 
 Lactobacillus iners 4,8% 0% 
 Lactobacillus crispatus 4,4% 0% 
 Megasphaera micronuciformis 1,3% 0% 
 Granulicatella adiacens_balaenopterae 1,1% 2,9% 
 Not annotated  0% 0,3% 
 Peptostreptococcus stomatis 0,9% 0,3% 
 Selenomonas infelix 5,3% 1,7% 
 BVAB-1  1,2% 0% 
 Staphylococcus  4,8% 0% 
 Streptococcus dentisani_tigurinus_oralis 15,6% 39,4% 
 Streptococcus anginosus 0% 0,9% 
 Veillonella dispar 4,6% 5,2% 
   0% 0,1% 
 Gemella sanguinis_morbbilliorum_heamolysans  2,6% 5,7% 
Fusobacteria Fusobacterium periodonticum 3,7% 2,4% 
 Leptotrichia wadei 4,3% 2,6% 
 Sneathia  0,9% 0% 
Proteobacteria Aggregatibacter aphrophilussaccharolyticum 1,4% 1,3% 
 Campylobacter showae_rectus  2,3% 0,8% 
 Kingella denitrificans 0% 0,8% 
 Haemophilus parainfluenzae  5,5% 9,4% 
 Haemophilus influenzae 0% 0,7% 
 Lautropia mirabilis 2,2% 4,9% 
 Neisseria mucosa_macacae 3,3% 7,0% 
Spirochaetes Treponema  0,9% 0,3% 
SR1   0,6% 0% 
Synergistetes TG5  0% 0,2% 
*Taxa merged at lowest annotation level possible.  
* Species annotation with lower than 97% identity using BLASTn to search the eHOMD database 
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Figure 3.6: Taxonomical differences between oral community types and ecological niches. Oral samples (N=165) 
were used to build a negative binomial model to identify bacterial present at relatively different proportions 
between (A) oral community types defined using fuzzy clustering with an optimal k and (B) oral sampling site (salivary 
(SAL) versus periodontal (PE)). Dashed lines indicate a fold change > 1.25 or <0.75. Relative fold differences have 
been displayed as log2 (fold change) for illustrative purposes and the true fold differences are summarised in 
Appendix, Table S3. All OTUs included had a significantly different relative abundance (adjusted p-value < 0,05). The 
same sample set was used to train a random forest model to predict the most important taxa differentiating (C) oral 
community types (OCT1 vs OCT2) and (D) oral sampling site (SAL vs PE), with the mean decrease in the Gini 
coefficient for the top 30 most important taxa displayed in (B). For (A) and (C), OCT 1 and PE samples were used as 
reference levels for (A)+(C) and (B)+(D) respectively. * Indicate species annotation with lower than 97% identity using 
BLASTn to search the eHOMD database.  
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4.3.2 Description of the core oral microbiota 
Ecological community analysis (Figure 3.4 A and 3.4 C) and unsupervised hierarchical clustering 
of oral samples (Figure 3.5 A) did not reveal any sampling site specific separation between SAL 
and PE samples. Based on this, samples from both sampling sites were analysed together for 
descriptions of a core oral microbiota. Of the 775 OTUs present in at least 10% of all oral samples 
at a relative abundance higher than 0.01%, 560 were ubiquitous across oral sampling sites and 
101 and 114 were present in only PE and SAL samples, respectively. For the description of the 
core microbiota, OTUs present in at least 50% of both SAL and PE samples with a relative 
abundance larger than 0.01% were included. Figures 3.7 illustrates how the prevalence of core 
oral microbiota changes when using different relative abundance detection thresholds and Table 
3.3 summarizes the relative abundance of core oral taxa on a genus and species level. The oral 
core microbiota was dominated by Firmicutes (41%) followed by Proteobacteria (26%), 
Bacteriodes (18%), Fusobacteria (9%) and Actinobacteria (6%) (Table 3.3). On a genus and species 
level, the core oral microbiota was comprised of Streptococcus [S. dentisani_tigurinus_oralis 
(29%), S. anginosus (1%)], Haemophilus [H. parainfluenzae (8%), H. influenzae (1%)], Prevotella 
[P. melaninogenica (3%), P. intermedia (2%), P. oris (1%)], LactobacilLus [L. iners (3%), L. crispatus 
(3%)], Neisseria [N. mucosa_macacae (5%)] and Veillonella [V. dispar (5%)] (Table 3.3) 
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Figure 3.7: Core analysis of the oral microbiota Relative prevalence of core OTUs at different cut offs of minimal 
relative OTU prevalence. All core analysis were done on combined periodontal and saliva samples (N= 165) including 
OTUs with at least 10 counts present in at least 50% of samples. * Indicate species annotation with lower than 97% 
identity using BLASTn to search the eHOMD database. 
 
 
Table 3.3: Mean relative abundance of core oral taxa** 
OTU Phylum Genus Species 
Mean 
Relative 
Abundance 
OTU_32 Actinobacteria Actinomyces oris_naeslundii _viscosus* 2% 
OTU_24  Corynebacterium  2% 
OTU_6  Gardnerella  1% 
OTU_39  Rothia mucilaginosa_cluster 1% 
OTU_29 Bacteroidetes Porphyromonas pasteri* 1% 
OTU_18  Prevotella intermedia* 2% 
OTU_14  Prevotella melaninogenica 3% 
OTU_100  Prevotella oris 1% 
OTU_19 Firmicutes Abiotrophia defective 1% 
OTU_67  Catonella morbi 0% 
OTU_1  Lactobacillus iners 3% 
OTU_3  Lactobacillus crispatus 3% 
OTU_713  Granulicatella adiacens_balaenopterae 2% 
OTU_26  Peptostreptococcus stomatis 1% 
OTU_28  Selenomonas infelix 4% 
OTU_4  BVAB-1  1% 
OTU_16  Staphylococcus  4% 
OTU_58  Streptococcus anginosus 1% 
OTU_2  Streptococcus dentisani_tigurinus_oralis 29% 
OTU_17  Veillonella Dispar 5% 
OTU_8  Gemella 
sanguinis_morbbilliorum_heamolysans
* 4% 
OTU_31 Fusobacteria Fusobacterium periodonticum* 3% 
OTU_38  Leptotrichia wadei 3% 
OTU_30 Proteobacteria Aggregatibacter aphrophilussaccharolyticum* 1% 
OTU_41  Campylobacter showae_rectus  2% 
OTU_40  Kingella denitrificans* 1% 
OTU_5  Haemophilus parainfluenzae * 8% 
OTU_934  Haemophilus influenzae* 1% 
OTU_12  Lautropia mirabilis* 4% 
OTU_9  Neisseria mucosa_macacae* 5% 
* Species annotation with lower than 97% identity using BLASTn to search the eHOMD database 
** Taxa merged at lowest annotation level possible.  
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4.4 Description of the vaginal microbiome 
 
In accordance with previously published research (Ravel et al. 2011; Lennard et al. 2018), 
participants with a clinical diagnosis of BV determined by Nugent scoring presented with a 
diverse vaginal microbiota comprised of a high relative abundance of BV-associated bacteria 
including Gardnerella, Prevotella, BVAB-1, Aerococcus, Megasphaera, Sneathia and Atopobium 
(Figure 3.9). In comparison to participants diagnosed with BV, BV negative participants presented 
with a vaginal microbiota dominated by Lactobacillus spp. (Figure 3.9). In agreement with 
previous publications on the vaginal microbiota of participants from the same population as this 
study (Balle et al. 2018; Lennard et al. 2017), three distinct vaginal community types (termed VCT 
1, VCT 2 and VCT 3 for distinction from oral community types) were delineated using fuzzy 
clustering with an optimal k (Figure 3.9). Of the 93 samples that were retained after quality 
assessment, 51% (N = 48) belonged to community type 2 (VCT 2), distinguished by a diverse 
vaginal microbiota dominated by BVAB-1 (21%), Prevotella (19%), Gardnerella (19%), 
Megasphaera (11%), Sneathia (9%) and Lactobacillus (9%) (Figure 3.9 C). The remainder of the 
participants were split between VCT 1 (25%, N= 23) and VCT 3 (22%, N=22) and displayed low 
diversity community types dominated by Lactobacillus (93,7% and 92% respectively), with VCT 1 
consisting of majority L. crispatus (87.3%) and VCT 3 L. iners (80%) (Figure 3.9 C). Shannon’s 
diversity Index was significantly higher in VCT 2 [Median (variance) = 2.14 (0.27)] compared to 
both VCT 1 [Median (variance) = 0.49 (0.47)] and VCT 3 [Median (variance) = 0.61 (0.34)] (Figure 
3.8 A). NMDS analyses of beta diversity revealed VCT 1 and VCT 3 to be similar in terms of 
community membership while both distinct from VCT 2 (Figure 3.8 B). Linear regression revealed 
VCT 2 to have significantly higher Shannon’s diversity (p<0.005) in comparison to both VCT 1 and 
VCT 3, between which there were no significant differences. The majority of the participants with 
a VCT 2 vaginal microbiota had a clinical diagnosis of BV at the time samples were collected while 
0% and 4% of participants with to VCT 1 and VCT 3 microbiotas respectively, were diagnosed as 
BV negative through Nugent scoring. We used negative binomial modelling to determine the 
quantitative relative difference between bacterial taxa in vaginal communities of participants 
with and without clinical BV diagnoses and different VCTs. Participants with a clinical BV diagnosis 
had significantly increased proportions of Actinobacteria (Gardnerella, Atopobium, Mobiluncus 
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and OTU_104 (Not annotated), Bacteroidetes (Prevotella and OTU_181 (Not annotated), 
Fusobacteria (Sneathia) and TM7 in comparison to participants without clinical BV (Figure 3.10 
A, Appendix, Table S7). The Firmicutes; Aerococcus, Clostridium, Dialister, Gemella, 
Megasphaera, Parvimonas, BVAB-1 and Veillonella were enriched in the vaginal microbiota of BV 
positive participants, while a number Lactobacillus spp. (L. iners, L. reuteri, L. jensenii and L. 
crispatus) were enriched in participants with no clinical vaginal microbial dysbiosis. Similar 
differences were observed when comparing VCT 2, the VCT associated with a clinical BV diagnosis 
with VCT 1 and VCT 3 (Figure 3.10 B-C, Table S7). Compared to VCT 1 and VCT 3, VCT 2 was 
enriched in Actinobacteria (Gardnerella, Atopobium, Corynebacterium and OTU 104 (Not 
annotated), Bacteroidetes (Prevotella spp. and OTU_181 (Not annotated), Fusobacteria 
(Sneathia) and a number of Firmicutes (Aerococcus, Clostridium, Dialister, Gemella, 
Megasphaera, Parvimonas and BVAB-1) (Figure 3.10 B and C). In comparison to VCT 2, both VCT 
1 and VCT 3 were enriched in a number of Lactobacillus spp., Corynebacterium, Clostridium and 
Mogibacterium, with VCT 1 having higher proportions of Acinetobacter and VCT 3 having higher 
proportions of Porphymonas, 1-68 and Staphylococcus. Additionally, this analysis illustrated the 
relative differences between the Lactobacillus dominant community types, with VCT 1 having a 
relatively larger presence of L. crispatus and VCT 3 of L. iners (Figure 3.10 D). 
 
 
 
 
 
 
 
 
 
Figure 3.8: Ecological diversity of vaginal microbiota by clinical BV status and vaginal community types. 
Comparison of ecological diversity of vaginal samples (N=93) by alpha diversity measured by Shannon’s Index (A) 
and NMDS analysis of beta diversity using Bray-Curtis as a distance metric (B) of bacterial community diversity in the 
vagina. Colour denotes vaginal community type (VCT 1 = blue, VCT 2 = pink, VCT 3 = green) determined by fuzzy 
clustering using optimal k and shape denotes clinical bacterial vaginosis diagnosis (round = negative, triangle = 
positive). *** denotes p <0,001.  
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Figure 3.9: Composition of vaginal bacterial community types (A) Relative standardised read counts of the 30 top 
most abundant bacterial taxa in vaginal samples (N=95) clustered by UPGMA hierarchical clustering with colour scale 
indicating the relative read count of different bacterial taxa in each sample and colour key denoting vaginal 
community type (VCT) and clinical BV status. The composition of vaginal community types and differences in vaginal 
microbiota of participants diagnosed with BV compared to those without were additionally visualised with the 
relative abundance of bacterial taxa agglomerated at the on a (B) genus and (C) species level. The x-axis denotes 
sample type and the y-axis denotes % relative abundance of bacterial taxa contributing to the total makeup of the 
microbiota (100%).  
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Figure 3.10: Differentially abundant vaginal bacterial taxa between vaginal community type. Vaginal samples 
(N=93) were used to build a negative binomial model to identify bacteria present at relatively different proportions 
(p adjusted <0.05) in the vaginal microbiota between (A) participants with and without a clinical diagnosis of BV 
(N=93). We additionally identified differentially abundant taxa between (B) VCT 2 and VCT 1 (N =71), (C) VCT 2 and 
(D) VCT 3 (N=70) and VCT 1 and VCT 3 (N=45). Relative fold differences have been displayed as log2(fold change) for 
illustrative purposes and the true fold differences are summarised in Appendix, Table S7. Dashed lines indicate a fold 
change > 1.25 or <0.75. 
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4.5 Comparison of the oral and vaginal microbiota 
 
Bacterial communities in the mouth and vagina of South African adolescent females were distinct 
in terms of both alpha and beta diversity (Figure 3.11 A and 8B). The bacterial composition of the 
oral microbiota was found to be more diverse than that of the vaginal microbiota with 866 unique 
OTUs identified from oral samples compared to 364 OTUs identified from vaginal samples. When 
combining SAL and PE samples, median alpha diversity as measured by Shannon’s Index was 
significantly higher than that of vaginal samples (p<0,001, Figure 3.11 A). Tables 3.4 and 3.5 
summaries the top most abundant OTUs present across all oral and vaginal samples respectively. 
Unsupervised hierarchical clustering of standardised read counts resulted in distinct oral and 
vaginal clusters (Figure 3.11 C). Figure 3.11 C illustrates the top 30 most abundant OTUs present 
across all libraries and standardised read counts of these OTUs across all samples. The majority 
of oral samples clustered into one distinct group characterised by high read counts of bacterial 
genera known to be present in the oral microbiota including Streptococcus, Veillonella, Neisseria, 
Haemophilus, Porphyromonas, Actinomyces and Gemella (as described in section 4.3, Figure 3.11 
C, 3.11 A and 3.11 B). The vaginal samples separated into two distinct clusters with one group 
having higher read counts of Lactobacillus spp. and the other enriched with BV-associated 
bacteria including BVAB-1, Gardnerella, Megasphaera, Atopobium, Prevotella and Sneathia 
(Figure 3.11 C, 3.11 A and 3.11 B). Within the lactobacilli dominant group there was distinct 
separation of two groups, one dominated by L. iners and the other by L. crispatus.  
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Figure 3.11: Microbial communities in the vagina, saliva and periodontal space (N= 258). Comparison of alpha 
diversity of oral and vaginal samples by Shannon’s diversity index (A) and NMDS analysis of beta diversity using Bray-
Curtis as a distance metric (B). Standardised mean read counts of oral and vaginal samples were grouped using 
UPGMA hierarchical clustering (C). Taxa were merged at the lowest taxonomic level available and only OTUs with 
more than 10 counts present in at least 10% of samples were selected. Colour scale indicates the relative read count 
of bacterial taxa present in each sample. The colours key indicates sampling site from which samples originated with 
purple denoting vagina (LW), yellow saliva (SAL) and orange periodontal (PE). * Indicate species annotation with 
lower than 97% identity using BLASTn to search the eHOMD database. 
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Figure 3.12: Microbial composition of oral and vaginal microbiota. Comparison of the relative abundance of sample 
counts merged at the (A) phylum and (B) genera level including only OTUs where at least 10% of samples have more 
than 10 counts of that OTU. The x-axis denotes sample type and the y-axis denotes % relative abundance of bacterial 
taxa contributing to the total makeup of the microbiota (100%).  
 
(A) 
(B) 
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Table 3.4: Mean relative abundance of top 30 most prevalent OTUs in all oral samples** 
OTU Phylum Genus Species 
Mean 
Relative 
abundance 
OTU_32 Actinobacteria Actinomyces oris_naeslundii _viscosus* 2% 
OTU_24  Corynebacterium  2% 
OTU_6  Gardnerella Vaginalis 1% 
OTU_39  Rothia mucilaginosa_cluster 1% 
OTU_29 Bacteroidetes Porphyromonas pasteri* 3% 
OTU_18  Prevotella intermedia* 2% 
OTU_14  Prevotella Melaninogenica 3% 
OTU_10  Prevotella  4% 
OTU_19 Firmicutes Abiotrophia defective 1% 
OTU_1  Lactobacillus Iners 3% 
OTU_3  Lactobacillus Crispatus 2% 
OTU_7  Megasphaera Micronuciformis 1% 
OTU_713  Granulicatella adiacens_balaenopterae 2% 
OTU_26  Peptostreptococcus Stomatis 1% 
OTU_28  Selenomonas Infelix 4% 
OTU_4  BVAB-1  1% 
OTU_16  Staphylococcus  3% 
OTU_58  Streptococcus Anginosus 1% 
OTU_2  Streptococcus dentisani_tigurinus_oralis 27% 
OTU_17  Veillonella Dispar 5% 
OTU_8  Gemella sanguinis_morbbilliorum_heamolysans * 4% 
OTU_31 Fusobacteria Fusobacterium periodonticum* 3% 
OTU_38  Leptotrichia Wadei 4% 
OTU_11  Sneathia  1% 
OTU_30 Proteobacteria Aggregatibacter aphrophilussaccharolyticum* 1% 
OTU_41  Campylobacter showae_rectus  2% 
OTU_5  Haemophilus parainfluenzae * 7% 
OTU_12  Lautropia mirabilis* 4% 
OTU_9  Neisseria mucosa_macacae* 5% 
OTU_143 Spirochaetes Treponema  1% 
* Species annotation with lower than 97% identity using BLASTn to search the eHOMD database 
** Taxa merged at lowest annotation level possible 
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Table 3.5: Mean relative abundance of top 30 most prevalent OTUs in all vaginal samples** 
OTU Phylum Genus Species 
Mean 
relative 
abundance 
OTU_22 Actinobacteria Atopobium vaginae 2,0% 
OTU_24  Corynebacterium  0,1% 
OTU_6  Gardnerella vaginalis 10,3% 
OTU_106  Mobiluncus  0,2% 
OTU_104 Not annotated   0,2% 
OTU_54 Bacteroidetes Porphyromonas  0,3% 
OTU_14  Prevotella melaninogenica 0,1% 
OTU_10  Prevotella  10,1% 
OTU_121  Prevotella pallens 0,3% 
OTU_48 Firmicutes Aerococcus  0,6% 
OTU_71  Anaerococcus  0,3% 
OTU_56  Clostridium  0,4% 
OTU_49  Dialister  0,6% 
OTU_27  Finegoldia  0,2% 
OTU_1  Lactobacillus iners 23,9% 
OTU_3  Lactobacillus crispatus 25,7% 
OTU_115  Lactobacillus reuteri 0,2% 
OTU_7  Megasphaera micronuciformis 6,0% 
OTU_8  Gemella sanguinis_morbbilliorum_heamolysans * 0,1% 
OTU_1680  Parvimonas   0,3% 
OTU_53  Peptoniphilus  0,4% 
OTU_26  Peptostreptococcus stomatis 0,1% 
OTU_4  BVAB-1  11,1% 
OTU_16  Staphylococcus  0,1% 
OTU_2  Streptococcus dentisani_tigurinus_oralis 0,4% 
OTU_34  Veillonella  0,6% 
OTU_65  WAL_1855D  0,2% 
OTU_31 Fusobacteria Fusobacterium periodonticum* 0,3% 
OTU_11  Sneathia  4,5% 
OTU_77 Tenericutes Mycoplasma  0,3% 
* Species annotation with lower than 97% identity using BLASTn to search the eHOMD database 
** Taxa merged at lowest annotation level possible 
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4.6 Association between oral and vaginal microbial dysbiosis 
To our knowledge, no study has characterised the oral microbiota of women with and without 
clinical BV or investigated how different vaginal bacterial community types may relate to oral 
community types. In order to gain a greater understanding of the relationship between the oral 
and vaginal microbiota, we compared the oral microbiota of female adolescents with both 
different VCTs and clinical BV. The prevalence of clinical BV was higher in participants with OCT 
1 (55%) compared to OCT 2 (43%) (Table 3.6). This was confirmed by a higher proportion of girls 
in OCT 1 the diverse BV-associated VCT 2 (60%) compared to 46% of those in OCT 2 (Table 3.6).  
Considering alpha diversity measured by Shannon’s Index, NMDS analysis of the beta diversity of 
oral taxa (Figure 3.13 A-C) and linear regression of Shannon diversity, we did not find evidence 
that bacterial community diversity in the oral cavity is related to clinical BV status or VCT. 
Additionally, unsupervised hierarchical clustering of oral samples did not reveal any patterns in 
the microbial composition of the oral microbiota relating to clinical BV diagnosis or VCT (Figure 
3.13 D).  
Table 3.6: Distribution of clinical BV status and VCTs in OCTs 
  OCT  
  OCT 1 (N = 85) OCT 2 (N= 80 ) p-value* 
BV prevalence  55% (N = 47 ) 43% (N = 34) 0.1004  
VCT distribution VCT 1  22% (N = 19) 
 
 24% (N = 19) 
 
0.8313 
 VCT 2 60% (N = 51) 
 
46% (N = 37) 
 
0.0768 
 VCT 3 18% (N = 16) 30% (N = 24) 0.0941 
* z-score two-sample test for proportions 
The results of negative binomial modelling are summarised in Table 3.7, listing taxa that were 
found to be differentially abundant (adjusted p<0.05)  in the oral microbiota when comparing 
the cohort with respect to clinical BV status and VCT. Bacteroides heparinolyticus, a 
saccharolytic Bacteroides species commonly isolated from human periodontitis lesions (Bailey et 
al. 2019; Ashimoto et al. 1995), was found to be significantly enriched in the oral microbiota of 
participants with a clinical diagnosis of BV compared to those without (Table 3.7). A number of 
other PD associated bacteria including Prevotella spp. and Oribacterium parvum as well as 
Butyrivibrio hungatei were enriched in the oral microbiota of participants with BV compared to 
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participants with no clinically diagnosed vaginal microbial dysbiosis (Table 3.7). A reduction in 
Bacteriodetes pyogenes was observed in oral microbiota of BV positive participants compared to 
BV negative participants. When comparing the composition of the oral microbiota of this cohort 
with respect to VCT, there was a lower relative proportion of SR1 in the oral microbiota of 
participants with L. crispatus dominated VCT 1 microbiotas compared to L. iners dominated VCT 
2. A number of other bacterial taxa were found to be significantly different in this analysis but 
the fold-change was negligible (Table 3.7). Negative binomial modelling did not identify 
significant differences in the relative proportion of other red complex bacteria (Tannerella and 
Treponema) or PD associated bacteria (Fusobacterium, Eikenella, Peptostreptococcus and 
Campylobacter) in oral microbiota of participants with and without a clinical diagnosis of BV or 
different VCTs. Random forest modelling using all oral microbiota samples (N = 165) to predict 
clinical BV status (Sn = 0.63, Sp = 0.57) identified Delftia as being an important bacteria in 
differentiating between the oral microbiota of clinically BV negative and BV positive participants 
(Figure3.14 A) although negative binomial modelling did not find a significant difference in the 
oral presence of Delftia between participants with and without clinical BV (fold change = 0.32, 
p=1.00). Random forest models were additionally constructed to assess the ability of the 
composition of the oral microbiota to predict vaginal community between VCT 2 and VCT 1 (Sn = 
1.00, Sp = 0.00), VCT 2 and VCT 3 (Sn = 1.00, Sp = 0.00) and VCT 1 and VCT 3 (Sn = 0.52, Sp =0.51) 
and the important bacteria distinguishing these models are summarised in Figure 3.14 A- 3.14 D.  
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Figure 3.13: Ecological diversity of oral microbiota by clinical BV status and vaginal community type. (A) Shannon’s 
diversity and (B) NMDS analysis of beta diversity using Bray-Curtis as a distance metric of oral microbial communities 
with colour denoting vaginal community type (VCT 1 = blue, VCT 2 = pink, VCT 3 = green) denoted by fuzzy clustering 
of vaginal bacterial composition using optimal k and shape denoting clinical BV diagnosis by Nugent scoring (round 
= negative, triangle = positive). 
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Table 3.7: Results of a negative binomial model detecting significant differences in the relative abundance of oral bacterial taxa 
between participants with and without and clinical BV diagnosis and differing vaginal community types 
    Relative abundance fold change (adjusted p-value) 
    Clinical BV Vaginal Community Type 
Phylum Phylum Genus Species  Pos vs. Neg VCT 2 vs. VCT 1 VCT 2 vs. VCT 3 
OTU_151 Bacteroidetes Prevotella shahii_loescheii 2.06 (0.009)*   
OTU_221   albensis 1.29 (0.0326)   
OTU_307   enoeca 1.52 (0.0188)*   
OTU_405  Alloprevotella rava 1.17 (0.0003)   
OTU_588  Porphyromonas circumdentaria 0.97 (0.013)   
OTU_279   gingivicanis_circumdentaria_pasteri 1.09 (0.0037)   
OTU_424  Bacteroides zoogleoformans 0.88 (<0.0001) 1.09 (<0.0001) 1.05 (<0.0001) 
OTU_562   pyogenes 0.75 (0.0469)*   
OTU_241   heparinolyticus 3.29 (0.0014)*   
OTU_135 Firmicutes Butyrivibrio hungatei 3.07 (0.0159)*   
OTU_470  Centipeda periodontii 0.97 (<0.0001) 1.07 (<0.0001) 1.07 (<0.0001) 
OTU_492  Lachnospiraceae bacterium 0.95 (<0.0001)   
OTU_529  Oribacterium parvum 1.3 (0.0025)*   
OTU_602  Peptostreptococcaceae saphenum_sulci_infirmum 0.9 (<0.0001)   
OTU_420 Proteobacteria Desulfovibrio desulfuricans 0.94 (<0.0001)   
OTU_1229 SR1     0.67 (<0.0001)*  
OTU_447 Synergistetes Pyramidobacter piscolens 0.83 (0.0009)   
*  p-value > 0,05
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Figure 3.14: Top classification features in random forest modelling using oral bacterial composition to predict 
clinical BV status and vaginal community type. The oral samples were used to train a random forest model to 
predict the most important taxa to classify clinical BV diagnosis (N=258) (A) and vaginal community types (VCT) 
with VCT 2 vs. VCT 1 (N=60) (B), VCT 2 vs. VCT 3 (N=61) (C) and VCT 1 vs. VCT 3 (N=45) (D). The mean decrease 
in the Gini coefficient for the top 30 most important taxa are displayed.  
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CHAPTER 5: Discussion 
5.1 Study design and methodology 
 
To our knowledge, this study presents the first data on the characterization of the South 
African oral microbiota. Another strength of our study is the size of the cohort included and 
the use of MiSeq next generation sequencing for characterization of the oral microbiota. Our 
cohort consisted of 94 South African women between the ages of 15 and 19 years enrolled in 
the UChoose-A-Star clinical trial at the Desmond Tutu HIV Youth Centre in Masiphumelele, 
Cape Town. The size of our cohort is relatively larger than the majority of previously published 
studies describing the oral microbiota in other populations (Aas et al. 2005; Dalwai et al. 2007; 
Zaura et al. 2009; Dewhirst et al. 2010; Bik et al. 2010; Xie et al. 2010; Belda-Ferre et al. 2011; 
Pushalkar et al. 2012; Schmidt et al. 2014; Fourie et al. 2016; Al-hebshi et al. 2017). We utilised 
high throughput Illumina Miseq technology which has been shown, in comparison to targeted 
PCR approaches and other sequencing platforms, to provide DNA sequencing data with high 
accuracy and low error rates per reads (Ross et al. 2013; Nakazato et al. 2013). Using this 
technology, we were able to characterise a larger proportion of the existing taxa in both the 
oral and vaginal microbiota compared to the aforementioned studies. As this was a 
retrospective study utilising samples from a previous study focused on reproductive health, 
we were unable to collect data on important baseline factors including dental hygiene, 
smoking habits and antibiotic usage that have been shown to impact the composition of the 
oral microbiota, a limitation that must be considered when interpreting these results. Most 
importantly, we could not assess for the presence of dental caries or gingivitis/ periodontitis 
and thus could not determine the specific factors that may be driving the separation we 
observed between different oral community types. We were able to asses a number of other 
baseline characteristics known to be important for vaginal colonization (summarised in 
Results section 2) and did not find any significant difference between our comparator groups 
of those with and without a clinical diagnosis of BV.  
 
A common methodological challenge of 16S rRNA gene sequencing is achieving consistent 
and representative amplification of bacterial taxa present in biological samples. Differing DNA 
extraction methods and sequencing platforms have been shown to affect the representation 
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of specific bacterial taxa. Additionally, the amplification of different variable regions of the 
16S bacterial ribosomal gene have been shown to exhibit higher levels of variability for 
specific bacterial phyla and to provide varying amounts of species level resolution for selected 
bacterial families (Graspeuntner et al. 2018). In order to control for bias introduced by batch 
effects of differing MiSeq runs, we included all matched samples (vaginal lateral wall (LW), 
saliva (SAL) and periodontal (PE)) from the same participants within the same MiSeq run 
where possible. Our final sequence library was pooled from six MiSeq runs using samples 
extracted from two different extraction kits. Hierarchical clustering and ecological diversity 
analysis revealed no evidence for technical bias relating to DNA extraction methods or MiSeq 
runs. Negative controls included for both DNA extraction and PCR amplification steps, gave 
evidence for minimal environmental contamination. The inclusion of an even mock 
community of known bacterial composition demonstrated that although bacterial taxa were 
amplified consistently across MiSeq runs, amplification was not evenly representative for 
different taxa. Of all 22 bacterial taxa known to be present in the mock community, 
Propionibacterium acnes was not identified in any of the runs and Enterococcus, Neisseria 
cinerea, Pseudomonas aeruginosa and Escherichia coli were consistently overrepresented 
across all runs. The majority of studies describing the oral microbiome have amplified the V1 
and V2 hypervariable regions of the of the bacterial ribosomal gene, likely due to these 
regions demonstrating high level resolution for keystone oral bacteria including Streptococcus 
and Staphylococcus species (Chakravorty et al. 2008). For the purpose of this study we 
amplified the V4 region to facilitate a comparison of sequences from the oral and vaginal 
samples for which our group had already developed a V4 sequencing protocol. While the V4-
6 region is conventionally used as representative barcode for the majority of bacterial phyla 
(Yang et al. 2016), some studies have found difficulty in identifying Fusobacterium species in 
this region (Kumar et al. 2011). Results from our amplification of the mock communities 
demonstrated that we were able to differentiate between the two Streptococcus species 
present (S. mutans and S. agalactiae) but were unable to make a distinction between 
Staphylococcus aureus and S. epidermis, a limitation that must be considered when 
comparing the results of this study to other descriptions of the oral microbiota.  
 
Variability in sequencing depth is an additional difficulty encountered when analysing MiSeq 
sequencing data as the number of reads generated per sample can vary by orders of 
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magnitude within a single sampling run. For the purpose of this study we combined several 
MiSeq runs including both high DNA yield vaginal and low DNA-yield oral samples in our 
comparison. While historically studies have adjusted for high variability in read counts by sub-
sampling using read count rarefaction, this method results in a loss of valuable data and is 
inappropriate for determining differential abundance in sequencing libraries with high read 
count variability (Mcmurdie & Holmes 2014). To account for this variability in differential 
abundance testing we standardised our OTU tables by transforming each OTU count to 
relative abundance multiplied by median sample read and used a negative binomial model 
(utilised in the DeSeq package (Anders & Huber 2010)) to estimate differences in the relative 
abundance of bacterial taxa between comparison groups.  
 
5.2 Development of a sample processing protocol for stored samples with low DNA yields 
As detailed in Chapter 1, the study utilised a bacterial DNA extraction and 16S rRNA gene 
amplification protocol that had been previously developed for the preparation of bacterial 
16S V4 gene sequencing libraries using Illumina Miseq. Our initial attempts to extract DNA 
from stored saliva and periodontal samples did not result in sufficient DNA yields for 
downstream PCR amplification. This likely due to the overall low abundance of bacterial 
product present in these samples, in addition to the presence of salivary gland secretions 
thought to contain nucleases and proteins that may degrade DNA during extended sample 
storage and inhibit DNA amplification using PCR. After adding additional steps to our sample 
processing protocol, including boiling of samples (prior or post storage at -80°C) and removal 
of salivary supernatant to denature and remove potential inhibitors that may be interfering 
with DNA extractions and PCR reactions, for most samples collected we were able to extract 
sufficient DNA yields for PCR and downstream MiSeq DNA library preparation. The 
development of this protocol allowed for the extraction of 16S rRNA gene DNA from stored 
low-yield samples.   
 
5.3 Characterisation of the oral microbiota 
This study presents a description of the oral microbiota composition of 94 South African 
women aged 15-19, originating from salivary and periodontal samples. After filtering for OTUs 
that had at least 10 read counts in at least 10% samples, we identified 866 unique OTUs 
mapping to 213 genera and 193 identifiable species. This is higher than previous description 
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of oral bacterial diversity in other large scale population studies (Takeshita et al. 2016; Sarkar, 
Stoneking, and Nandineni 2017; Li et al. 2014a).  
 
Despite the number of physical and chemical exposures the oral cavity experiences on a daily 
basis, research indicates that a stable core oral microbiota exists (Li et al. 2013; Zaura et al. 
2009). In line with what has been previously published (Dewhirst et al. 2010; Bik et al. 2010; 
Zaura et al. 2009) we  found the core oral microbiota to be to be dominated by Firmicutes 
and Proteobacteria followed by Actinobacteria, Fusobacteria and to a small extent 
Spirochaetes. As expected, Streptococcus was the most prevalent bacterial genus, followed 
by Prevotella, Haemophilus, Lactobacillus, Neisseria, Veillonella, Leptotrichia, Lautropia, 
Selenomonas, Fusobacterium, Staphylococcus and Porphyromonas. A number of other 
bacterial genera species previously identified in the oral microbiota were identified at low 
levels including Actinomyces, Corynebacterium, Campylobacter, Aggregatibacter, 
Abiotrophia, Gardnerella, Rothia, Megasphaera, Treponema, Shuttleworthia, 
Peptostreptococcus and Sneathia.  
 
The structure of the oral cavity leads to the formation of different ecological niches, causing 
colonization by distinct bacterial community types. Mucosal surfaces including the palate, 
tongue, cheeks and tonsils house a variety of shedding bacteria that accumulate in saliva, 
whilst the enamelled covered surface of teeth or dentures favour the long-term formation of 
bacterial biofilms (Costalonga & Herzberg 2014). Of the 775 OTUs present in all oral samples, 
560 were ubiquitous across saliva and periodontal samples while 101 and 114 were unique 
to saliva and periodontal, respectively.  In this study, we did not identify differences between 
the salivary and periodontal microbiota in terms of ecological diversity or the composition of 
the most abundant bacterial taxa. Differential abundance testing of less prevalent bacterial 
species revealed higher proportions of Firmicutes (Oribacterium spp. and Streptococcus 
anginosus), Prevotella nanceiensis and Actinobacteria (Actinomyces graevenitzii and Rothia 
mucilaginosa) in the saliva compared to the periodontal space. In contrast, periodontal 
samples were enriched in a single Fusobacteria OTU mapping to the Leptotrichia genus. This 
is in agreement with previous studies reporting the oral mucosal surfaces to be largely 
dominated by Firmicutes and the dental plaque to host a more diverse range of Firmicutes, 
Bacteroidetes, Actinobacteria, Proteobacteria and Fusobacteria (He et al. 2015; Aas et al. 
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2005). In a study comparing nine ecological niches in the oral environment, samples from the 
teeth, including both the sub- and supra-gingival plaque, had the lowest proportion of 
Firmicutes and relatively larger proportion of Actinobacteria (Segata et al. 2012). 
 
The extent to which host genetics determine the composition of the oral microbiota is not 
well understood. While one study found that the salivary microbiota did not vary across 
individuals from twelve locations worldwide (Nasidze et al. 2009), another study comparing 
saliva from Alaskan, German and African (originating from Democratic republic of Congo 
(DRC), Sierra Leone and Uganda) individuals found significantly higher bacterial diversity in 
the oral microbiotas of Africans compared to those from Northern countries (Li et al. 2014b). 
This study, which utilised the Genome Sequencer FLX platform, identified 62 genera in the 
Alaskan cohort, 58 genera in the German cohort and 100 genera in the African cohort. In a 
study of 2,343 healthy individuals, Neisseria and Haemophilus were found to dominate the 
salivary microbiota of Korean individuals, while Prevotella and Veillonella were most 
prevalent amongst Japanese individuals (Takeshita et al. 2016). In our study, a single OTU 
comprised 27% of the oral microbiota mapping to a cluster of Streptococcus species including 
S. dentisani, S. oralis and S. tigurinus. All three Streptococcus species have been identified in 
the oral microbiome. While S. tigurinus has been associated with infective endocarditis 
(Zbinden et al. 2012; Zbinden et al. 2015; Zbinden et al. 2014), S. dentisani and S. oralis are 
associated with oral health and are both candidates for landmark oral species  (López-López 
et al. 2017). S. oralis is the most commonly identified in the oral microbiome, reported as one 
of the early colonisers of the oral microbiome and involved in maintaining oral biofilm 
integrity allowing for further bacterial colonisation of species associated with good oral health 
(including S. parasanguinis, A. defectiva, S. mitis, and S. sanguinis) (Peterson et al. 2013; Corby 
et al. 2005; Paddick et al. 2003). S. dentisani has been reported to confer dual probiotic action 
in the oral bacterial ecosystem by inhibiting the growth of major oral pathogens through the 
production of bacteriocins and buffering acidic oral pH (the main cause of dental carries) 
through the production of ammonia in the presence of arginine (López-López et al. 2017).   
 
A study in 161 Italian participants identified 3 “salivary types’ characterised by increased 
relative abundance of Prevotella, Streptococcus/Gemella and Fusobacterium/Neisseria with 
the Prevotella and Streptococcus/Gemella salivary composition associated with poor oral 
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health (Filippis et al. 2014). In another cohort of 200 healthy Japanese individuals, three 
salivary types were defined as being Prevotella/Veillonella-dominant, Streptococcus-
dominant and Neisseria, Haemophilus, or Aggregatibacter/Porphyromonas-dominant with 
the first two salivary types associated with a higher percentage of periodontal pockets. We 
identified two distinct oral community types (OCTs) that did not correlate with sampling site. 
Oral community type one (OCT 1) was characterised by a diverse make up of oral bacteria 
while OCT 2 was enriched in the Streptococcus dentisani_tigurinus_oralis cluster previously 
described as the most abundant OTU across all oral samples. A limitation of this study was 
our inability to establish oral health (defined by periodontitis diagnosis) and oral health 
practices at the time sample collection. Due to this we are unable to determine whether a 
Streptococcus dominated oral microbiota in the South African population is associated with 
poor oral health as previously described or if the dominant Streptococcus species is indeed S. 
dentisani or S. oralis conferring protection against invasive oral bacterial species.  Targeted 
qPCR would assist in resolving the species level classification and should be a consideration 
for future work.  
 
While one study has attributed differences in the oral microbiota of African hunter-gatherers 
from Uganda  compared to agricultural groups in DRC and Sierra Leone to differences in 
lifestyle and diet (Nasidze et al. 2009), another study found no differences in composition of 
oral microbiota of omnivores, ovo-lacto-vegetarians and vegan individuals (Filippis et al. 
2014). Altered oral microbiota have been identified as a marker of systemic disease (Long et 
al. 2017; Roda et al. 2008; Michaud & Izard 2014; Kistler et al. 2018; Lerner et al. 2016; Hayashi 
et al. 2010). Distinct oral microbiota have additionally been observed for non-disease states, 
for example in pregnant and lactating women (Zarco et al. 2012), indicating that homeostatic 
alterations in the body may manifest in the oral microbiota. There it is important to 
understand what constitutes a ‘healthy’ or ‘optimal’ oral bacterial make up in order to 
recognize deviations from the state predictive of systemic disease. More research is needed 
into the association between oral and systemic health and the composition of the oral 
microbiota in the South African population.    
 
 
5.4 Characterisation of the vaginal microbial dysbiosis in South African female adolescents 
 
 96 
The current understanding of the composition of common vaginal community types (VCTs) is 
based on studies in North-American women where five or six vaginal community types have 
been described – four of which are dominated by a single lactobacilli species (L. crispatus, L. 
iners, L. gasseri or L. jensenii) and one to two characterised by a diverse vaginal microbiota 
comprised of strictly anaerobic BV associated bacteria ((Ravel et al. 2011; Kroon et al. 2018). 
North American studies describing the vaginal microbiome of asymptomatic women have 
shown Lactobacilli dominant VCTs to be more common in White and Asian women in while 
asymptomatic Hispanic and African-American women sometimes present with high bacterial 
diversity and low numbers of Lactobacillus(Fettweis et al. 2014; Zhou et al. 2011; Ravel et al. 
2011). 
 
This has led to a need for a change in the definition of what was previously considered a 
‘healthy’ or ‘optimal’ vaginal microbiota – that being one dominated by Lactobacillus bacterial 
commensal species, having a low vaginal pH (3.5-4.5), and having no Candida, STI or BV 
present. These studies originate from populations in which overall prevalence of BV is 
relatively low compared to the South African population in which the vaginal microbiota of 
women of reproductive age is characterised by low lactobacilli abundance, high bacterial 
diversity, a high prevalence of BV and a higher vaginal pH in comparison to their North 
American counterparts (Lennard et al. 2018; Anahtar et al. 2015). In this study, participants 
with clinically diagnosed BV (Nugent score >7) presented with a vaginal microbiota comprised 
of several BV associated bacteria in comparison to their BV-negative counterparts with 
lactobacilli dominant vaginal microbiotas. We additionally identified three distinct VCTs by 
fuzzy clustering. VCT 2, characterised by a diverse composition of BV-associated bacteria, was 
highly correlated with a clinical diagnosis of BV and in accordance with previous studies in the 
same population of young South African women (Lennard et al. 2017), participants without 
diagnosed BV clustered into two distinct VCTs dominated by either L. crispatus (VCT 1) or L. 
iners (VCT 3). These results were similar to a study in a different South African population 
where participants clustered in to four VCTs, two dominated by lactobacilli (L. crispatus and 
L. iners) and two BVAB VCTs differentiated by a dominance of Gardnerella and a consistent 
presence of Prevotella (Anahtar et al. 2015). Our study, in addition to the previously described 
studies in the South African populations, did not observe the separation into four distinct 
lactobacilli dominated VCTs as reported by Ravel et al. 2012. As in previous studies in the 
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South African population, L. gasseri and L. jensenii are only identified at low proportions in 
the South African vaginal microbiome, likely due to a combination of population specific 
variable including host genetics and lifestyle factors.   
 
Our results, in addition to the previously described studies, challenge the paradigm of 
associating a Lactobacillus dominant vaginal microbiome with functional characteristics of a 
‘heathy’ vaginal microbiome and high bacterial diversity and presence of BV-associated 
bacteria as the marker of an “unhealthy” vaginal microbiota characterised by high pH and 
inflammation on a clinical and sub-clinical level (Ma et al. 2012). Particularly the role of L. 
iners as a protective vaginal bacteria, with this Lactobacillus species identified in both optimal 
and dysbiotic VCTs (Petrova et al. 2017; Borgdorff et al. 2016). Studies have reported an  L. 
crispatus dominated VCT to be protective against BV, while L. iners dominance has been 
associated with increased vaginal pH (Ravel et al. 2011) and marker of a transition to BV 
characterised by the expansion of BV-associated bacteria (Van De Wijgert et al. 2014; 
Verstraelen et al. 2009). The underlying reason for the high prevalence of BV in African-
American women in comparison to their Caucasian counterparts is currently unknown 
(Peipert et al. 2008). Studies characterising non-dysbiotic vaginal microbiomes have reported 
a higher proportion of L. iners dominated VCTs in African-American women compared 
Caucasian women who were dominated by L. crispatus (Srinivasan et al. 2012). In addition to 
this, some asymptomatic African-American and black South African women present with 
diverse, non-lactobacilli dominant VCTs (Ravel et al. 2011; Van De Wijgert et al. 2014). These 
studies indicate that women of African descent are less likely to harbour L. crispatus vaginal 
bacteria and more likely to be colonized by L. iners.  Based on the potential contribution of L. 
iners to BV pathology, this  may be a driver for the high BV prevalence observed in women of 
African descent although the low rates of BV in some African countries leaves more to be 
determined (Anahtar et al. 2015; Kenyon et al. 2013). Further research is needed into the 
extent to which host genetics play a role in determining vaginal microbial composition, 
whether there are functional redundancies by which non-lactobacillus bacterial communities 
may facilitate lactic acid fermentation to maintain a protective vaginal microbiota, and to 
better define the determinants of a healthy vaginal microenvironment. 
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5.5 The relationship between oral and vaginal microbial dysbiosis 
Both PD and BV, conditions characterised by microbial dysbiosis, are associated with a two- 
to four-fold risk of PTB (Pretorius et al. 2007; Harper et al. 2012). Although ecological evidence 
of the co-occurrence of BV, PD and PTB supports an association between bacterial dysbiosis 
of the oral and vaginal microbiotas, few etiological studies have investigated a possible 
biological relationship between the oral and vaginal microbiotas. Furthermore, the difficulty 
in diagnosing and treating microbial dysbiosis has yielded mixed results of clinical trials of PD 
and/or BV treatment to reduce adverse birth outcomes (Srinivasan et al. 2009). One study 
identified increased proportions PD-associated oral bacteria including P. gingivalis, T. 
forsythia, P. intermedia, and P. nigrescens in oral cavity of women who had delivered preterm 
compared to those who did not (Lin et al. 2007). To our knowledge, no study has characterised 
the oral microbiota of women with and without clinical BV or investigated how different 
bacterial VCTs may relate to OCTs. In order to gain a greater understanding of the relationship 
between the oral and vaginal microbiota, we compared the oral microbiota of female 
adolescents with both different VCTs and with or without clinical BV. In this study, Bacteroides 
heparinolyticus, a saccharolytic Bacteroides species commonly isolated from human 
periodontitis lesions (Bailey et al. 2019; Ashimoto et al. 1995), was found to be significantly 
enriched in the oral microbiota of participants with a clinical diagnosis of BV compared to 
those without. A number of other PD associated bacteria (Prevotella spp., Oribacterium 
parvum and Butyrivibrio hungatei) were enriched in the oral microbiota of participants with 
BV compared to participants with no clinically diagnosed vaginal microbial dysbiosis. When 
considering VCTs of participants without diagnosed BV, those with an L. iners dominated VCT 
3 had significantly increased proportions of oral SR1 (Curtis et al. 2011; Campbell et al. 2013), 
a bacterial phylum elevated in PD-states, in comparison to those with an L. crispatus 
dominated vaginal microbiota. This data supports the hypothesis that vaginal microbial 
dysbiosis in linked to the expansion of sub-optimal lactobacillus species in the oral cavity, 
especially when considering the questionable role of L. iners as a dominant vaginal bacteria. 
The functional significance of this relationship is yet to be determined. The most commonly 
accepted hypothesis for the causal relationship between PD and PTB describes the 
hematogenous dissemination of inflammatory products released by red and orange complex 
bacteria in the oral cavity, resulting in a systemic inflammatory response that initiates uterine 
contractions and PTB (Pretorius et al. 2007). This has been supported by a number of studies 
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identifying an association between PD and increased markers of inflammation in the oral 
compartment (Konopka et al. 2003; Offenbacher et al. 1998) and systemically (Amar et al. 
2003; D’Aiuto et al. 2004). Few studies have investigated the association between PD, 
systemic inflammation and adverse birth outcomes but one study found that pregnant 
women with both PD and increased systemic CRP were at a higher risk of developing 
preeclampsia compared to women without PD and both low and high levels of systemic CRP 
(Ruma et al. 2008). Based on identification of known oral pathogens such a Fusobacterium in 
the amniotic fluid of women who delivered pre-term and the absence thereof in term births 
(Hill 1998), it has been suggested that oral pathogens themselves may migrate to the uterine 
tract, causing decidual and chorioamniotic infections (Pretorius et al. 2007), although the 
exact mechanism through which this happens has yet to be elucidated. If in fact there is an 
association between oral and vaginal bacterial dysbiosis, the direction of the relationship with 
regards to which compartment the dysbiosis originates (as summarised in Chapter Two, 
Figure 2.5) is still unclear.  
  
While these results strengthen the argument for a link between bacterial dysbiosis in the 
genital and oral tract, there are still a number of factors in the etiology of PD and BV that need 
to be elucidated. Studies identifying hereditary risk for PTB preterm (Flint Porter et al. 1997; 
Winkvist et al. 1998) and alleles of inflammation-related genes associated with a 
predisposition towards PD and/or BV has led to the hypothesis that the association between 
PD, BV and PTB may be modulated by host genetics that may influence susceptibility to 
colonization by anaerobic bacteria. Alternatively, maternal and/or foetal inflammatory 
immune reaction in response to microbial dysbiosis may be genetically determined. A better 
understanding of how differences in host genetics determine the composition of both VCTs 
and OCTs and how this in turn impacts inflammation on a localized and systemic level, is 
required to disentangle the relationship between BV, PD and PTB.  
 
 
5.6 Conclusions, relevance and further work 
 
To our knowledge, this study presents the first data on the characterization of the South 
African oral microbiota. We present findings in support of previous studies from other non-
African populations that the oral microbiota is one of the most diverse in human body. We 
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additionally reported a description the vaginal microbiome that is in agreement with previous 
studies in the South African population and in contrast with data originating in North 
American populations. Due to the retrospective nature of this study we were unable to 
establish key baseline characteristics that may impact oral health. Additionally we were 
unable to distinguish between key bacterial Streptococcus species comprising majority of the 
oral microbiota. These limitations impacted our ability to determine the functional and clinical 
relevance of the distinct oral community types we observed. In future, more advanced 
molecular typing to achieve a greater level of taxonomic resolution will greatly improve our 
understanding of what constitutes the optimal composition of the South African oral 
microbiome. Hormonal fluctuations, both endogenous and exogenous, have been shown to 
influence the composition of the oral and vaginal microbiome (Gajer et al. 2012, Prasana et 
al. 2018). Additionally, both hormonal shifts during pregnancy and exposure to oral 
contraceptives have been linked to adverse periodontal health  (Figuero et al. 2013, Prasana 
et al. 2018,  Prachi et al. 2019). Due to the cross sectional nature of this study, we were unable 
to investigate temporal shifts in the oral and vaginal microbiome relating to endogenous 
hormonal fluctuations and exposure to exogenous hormonal contraceptives. A longitudinal 
analysis of these compartments considering exposure to exogenous hormonal contraceptive 
is critical to better understand causality in the in the relationship between PD, BV and PTB 
and has been identified as potential for future work.  
 
This study additionally investigated the association between bacterial dysbiosis of the oral 
and vaginal tracts by comparing the oral bacterial composition of women with and without 
vaginal bacterial dysbiosis (measured by clinical BV criteria and vaginal community typing). 
We did not identify an association between vaginal microbial dysbiosis and an increased 
presence of “red-complex” of bacteria traditionally associated with PD, we report increased 
proportions of additional PD-associated bacterial species in the oral microbiome of women 
with clinically diagnosed BV compared to asymptomatic women. Additionally we observed 
the oral microbiome of women with L. iners dominant VCTs to be enriched with PD-associated 
bacterial species, an interesting finding considering recent reports of the expansion of L. iners 
populations as a marker of transitioning  from an optimal to dysbiotic vaginal microbiota. 
While this data provides evidence in support of a relationship between oral and vaginal 
dysbiosis, it unclear in which compartment bacterial dysbiosis would originate, should the 
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association holds true. Assessing the relationship between PD and BV could lead to potential 
screening and intervention programs to effectively identify and treat risk factors during 
pregnancy and reduce the amount of preventable maternal and infant deaths in Sub Saharan 
Africa.  
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